%PDF-1.3 % 4 0 obj <>>>/BBox[0 0 612 792]/Length 152>>stream xν0Oq &(G%.;)V4%j 8UCʊv;}{̏lixt\G80?"ĭBwyXHQH)x-]962+3 endstream endobj 7 0 obj <>>>/BBox[0 0 612 792]/Length 152>>stream xν0Oq &(G%.;)V4%j 8UCʊv;}{̏lixt\G80?"ĭBwyXHQH)x-]962+3 endstream endobj 3 0 obj <>>>/BBox[0 0 612 792]/Length 152>>stream xν0Oq &(G%.;)V4%j 8UCʊv;}{̏lixt\G80?"ĭBwyXHQH)x-]962+3 endstream endobj 5 0 obj <>>>/BBox[0 0 612 792]/Length 152>>stream xν0Oq &(G%.;)V4%j 8UCʊv;}{̏lixt\G80?"ĭBwyXHQH)x-]962+3 endstream endobj 6 0 obj <>>>/BBox[0 0 612 792]/Length 152>>stream xν0Oq &(G%.;)V4%j 8UCʊv;}{̏lixt\G80?"ĭBwyXHQH)x-]962+3 endstream endobj 1 0 obj <>>>/BBox[0 0 612 792]/Length 152>>stream xν0Oq &(G%.;)V4%j 8UCʊv;}{̏lixt\G80?"ĭBwyXHQH)x-]962+3 endstream endobj 9 0 obj <>stream Arbortext Advanced Print Publisher 9.0.114/W 2022-04-20T01:09:43-07:00 2022-03-23T12:24:22+05:30 application/pdf SUR-2021-358-ver9-Guo_4P 298..303 Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT uuid:0192f94e-6679-42a8-b804-ac1d59c89d9f uuid:197040de-c0a8-4a98-9986-6777bbf0e4f8 endstream endobj 10 0 obj <>stream x+| endstream endobj 11 0 obj <>stream xS**T0T0Biye( endstream endobj 12 0 obj <>stream x+| endstream endobj 13 0 obj <>stream xS**T0T0BiyA$ endstream endobj 14 0 obj <>stream x+| endstream endobj 15 0 obj <>stream xS**T0T0BiyJ% endstream endobj 16 0 obj <>stream x+| endstream endobj 17 0 obj <>stream xS**T0T0Biy8# endstream endobj 18 0 obj <>stream x+| endstream endobj 19 0 obj <>stream xS**T0T0BiyS& endstream endobj 20 0 obj <>stream x+| endstream endobj 21 0 obj <>stream xS**T0T0Biy\' endstream endobj 23 0 obj <>stream /GS1 gs BT /F6 1 Tf 9.843 0 0 9.843 59.7543 725.1588 Tm 0 0 0 rg 0 Tc 0 Tw [(blood)-253.3(supply)-254.2(in)-255.8(the)-252.3(oral)-253.3(cavity)-256.9(may)-253.4(make)-255.6(the)-252.3(risk)-257.7(factors)-251.8(for)]TJ 0 -1.1174 TD [(infection)-369.7(different)-363.7(from)-362.7(those)-363.7(of)-365(STIs)-362.3(in)-365.2(other)-363.9(parts)-363.7(of)-359.3(the)]TJ 0 -1.1116 TD [(body.)-272.8(Therefore,)-277.1(it)-267.4(is)-272.8(meaningful)-274(to)-273(evaluate)-272.9(the)-275.3(risk)-269.2(factors)]TJ T* [(for)-441(maxillofacial)-447(STI)-436.3(infection.)-442.2(Understanding)-443.8(the)-442.3(factors)]TJ T* [(causing)-234.6(infection)-237.2(and)-234.9(taking)-232.7(corresponding)-235.4(measures)-237.7(against)]TJ 0 -1.1174 TD [(these)-451.3(factors)-447.6(are)-449.1(valuable)-450.3(for)-446.7(improving)-449.1(the)-448.1(prognosis)-447.4(of)]TJ 0 -1.1116 TD (patients.)Tj /F4 1 Tf 8.9663 0 0 8.9663 59.7543 635.6408 Tm [(Patients)-334.4(and)-338.2(Methods)]TJ /F6 1 Tf 9.843 0 0 9.843 69.7323 619.1998 Tm [(This)-282(study)-276.1(was)-281.6(approved)-281.8(by)-278.7(an)-279.8(ethics)-279.7(committee)-287(and)-275.2(was)]TJ -1.0137 -1.1174 TD [(conducted)-359.1(under)-358(the)-350.2(guidance)-358(of)-353.5(internation)-9.2(al)-354.8(ethical)-357.2(stan-)]TJ 0 -1.1116 TD [(dards)-282.9(\(PKUSSIRB-202054051\).)]TJ 1.0137 -1.1116 TD [(From)-276.1(January)-274.8(1,)-269.5(2017,)-272.8(to)-273(December)-280.5(31,)-270.6(2020,)-272.8(all)-275.4(patients)]TJ -1.0137 -1.1174 TD [(with)-500.9(STIs)-494.8(who)-499.5(received)-497.4(sutures)-498.2(in)-497.7(this)-499.8(department)-499.8(were)]TJ 0 -1.1116 TD (enrolled.)Tj /F10 1 Tf 8.9663 0 0 8.9663 59.7543 540.6235 Tm [(Inclusion)-336.7(and)-335.7(exclusion)-332.6(criteria)]TJ /F6 1 Tf 9.843 0 0 9.843 69.7323 524.1826 Tm [(The)-305.2(inclusion)-310.8(criteria)-306.4(were)-307.1(as)-302.7(follows:)-309.4(patients)-305.1(with)-310.8(only)]TJ -1.0137 -1.1116 TD [(STIs)-345(due)-338.5(to)-336.4(oral)-339.7(and)-344.3(maxillofacial)-343.4(trauma)-344.3(\(with)-340.7(or)-336.2(without)]TJ 0 -1.1174 TD [(dental)-326(trauma\))-316.6(at)-320.3(the)-321.4(initial)-320.5(visit)-322.5(and)-315.5(patients)-322.4(with)-322.3(all)-321.5(types)]TJ 0 -1.1116 TD [(and)-200.3(severities)-198.8(of)-198(maxillofacial)-205.1(STIs)-195.3(that)-195.9(needed)-200.2(suturing.)-202.3(The)]TJ T* [(diagnoses)-300(of)-290.2(STIs)-293.2(in)-296.1(the)-292.6(electronic)-298.2(records)-297.8(were)-295.6(as)-291.2(follows:)]TJ 0 -1.1174 TD [(laceration)-223.4(and)-223.3(avulsion,)-220.8(puncture,)-222(cutting)-216.6(injury,)-223.4(bite,)-216.6(animal)]TJ 0 -1.1116 TD [(bite,)-435.5(and)-436.4(blast)-433(injury.)-436.5(Even)-433(if)-434.3(some)-432.8(wound)-432.6(age)-437.6(exceeded)]TJ T* [(24)-388.1(hours)-379.7(or)-388.1(the)-379(wound)-386.5(had)-384.6(mild)-386(infection)-387(or)-382.3(necrosis,)-382.9(the)]TJ T* [(physician)-323.3(performed)-318.6(debridement)-316.6(and)-315.5(suturing)-319.9(at)-314.5(the)-315.6(initial)]TJ 0 -1.1174 TD (visit.)Tj 1.0137 -1.1116 TD [(Patients)-241.6(with)-241.7(complete)-244.2(electronic)-240.7(medical)-243.1(records,)-243.6(includ-)]TJ -1.0137 -1.1116 TD [(ing)-395.1(gender,)-398.2(age,)-395(physical)-397.1(condition,)-400.8(visit)-391.6(time,)-396.4(chief)-399.6(com-)]TJ 0 -1.1174 TD [(pl)14.9(ai)13.8(nt)14.9(,)-205(e)0(x)13.9(a)0(m)12.7(i)0(n)20.7(a)0(t)13.8(i)0(o)15(n)0(,)-200.4(d)0(i)15(a)0(g)19.7(n)0(o)15.1(s)0(i)15.1(s)0(,)-200.2(a)0(t)13.8(t)0(e)13.8(n)0(d)20.8(i)0(n)15(g)-208.4(ph)15.1(ys)15.3(ic)19.6(ia)13.8(n,)-200.4(tr)15(ea)18.5(tm)13.7(en)13.9(t,)]TJ 0 -1.1116 TD [(and)-373.1(appointment)-373.2(records)-372.6(were)-376.2(included.)-371.9(Patients)-374(who)-372.8(nee-)]TJ T* [(ded,)-226.8(in)-227(addition)-229.2(to)-221.2(the)-229.2(initial)-228.4(visit,)-228(at)-222.4(least)-232.5(one)-223.3(follow-up)-229.8(visit)]TJ 0 -1.1174 TD [(two)-223.2(days)-224.2(or)-221(more)-225.6(after)-226.8(suturing)-222(to)-221.2(evaluate)-226.8(whether)-224.1(infection)]TJ 0 -1.1116 TD (occurred.)Tj 1.0137 -1.1116 TD [(The)-581.6(exclusion)-582.5(criteria)-582.8(were)-577.8(as)-579.1(follows:)-585.8(patients)-581.5(with)]TJ -1.0137 -1.1174 TD [(incomplete)-517.2(elect)-9.3(ronic)-513.6(medical)-513.8(records;)-517.9(patients)-518.2(with)-512.4(jaw)]TJ 0 -1.1116 TD [(fractures)-209.1(or)-198(serious)-204.4(trauma)-206.1(of)-198(other)-202.6(parts)-202.4(of)-203.8(the)-200.4(body;)-201.5(patients)]TJ T* [(who)-430.4(received)-428.3(sutures)-429(at)-423.9(other)-427.2(hospitals;)-432.8(patients)-426(who)-424.6(had)]TJ T* [(serious)-440.6(wound)-432.6(infections)-439.7(that)-432(could)-438.8(not)-429.7(be)-435.3(sutured)-440.8(at)-429.7(the)]TJ 0 -1.1174 TD [(initial)-481.8(visit)-472.2(and)-476.8(sutured)-481.1(at)-475.8(the)-476.9(subsequent)-479.6(visit)-478(when)-473(the)]TJ 0 -1.1116 TD [(infection)-191.1(was)-189.5(reduced;)-191(patients)-189.9(who)-188.5(had)-188.8(only)-188.8(medical)-191.2(records)]TJ T* [(of)-370.8(the)-361.7(rst)-367(visit)-368.6(or)-365(only)-367.4(follow-up)-368.1(records)-366.9(within)-370.7(48)-365.1(hours)]TJ 0 -1.1174 TD [(after)-347.7(suture;)-343(patients)-345.4(who)-344(were)-347.4(American)-342.8(Society)-350(of)-342(Anes-)]TJ 0 -1.1116 TD [(thesiologist)-8.9(s)-277.4(\(ASA\))-283.5(grade)-284.3(4)-277.6(o)0(r)-278.6(5)0(.)]TJ /F10 1 Tf 8.9663 0 0 8.9663 59.7543 215.4897 Tm (Classication)Tj /F6 1 Tf 9.843 0 0 9.843 69.7323 199.0488 Tm [(The)-368.5(patients)-374.2(were)-370.4(divided)-372(into)-367.5(four)-367.2(groups)-369.2(according)-370.6(to)]TJ -1.0137 -1.1174 TD [(their)-329.4(age:)]TJ /F7 1 Tf 4.1815 0 TD (<)Tj /F6 1 Tf .5472 0 TD [(18)-330.5(years)-330.1(old,)-329.4(1844)-328.1(years)-330.1(old,)-329.4(4564)-328.1(years)-330.1(old,)]TJ -4.7287 -1.1116 TD (and)Tj /F7 1 Tf 1.7452 0 TD ()Tj /F6 1 Tf .72 0 TD [(65)-295.9(years)-295.6(old.)-294.9(The)-299.4(patients)-294.6(physical)-299.2(condition)-299.4(was)-293.1(di-)]TJ -2.4652 -1.1116 TD [(vided)-335.1(into)-338.7(three)-336.2(categories)-338.2(according)-341.8(to)-330.6(ASA)-338.9(grade:)-337.3(no)-330.5(or-)]TJ T* [(ganic)-549.4(disease)-546.6(\(grade)-550.3(1\);)-544.8(mild/moderate)-550.7(systemic)-547.9(disease)]TJ 0 -1.1174 TD [(without)-417.9(functional)-411.1(impairment)-419.3(\(grade)-412(2\);)-412.3(and)-413.4(organic)-413.3(dis-)]TJ 0 -1.1116 TD [(ease)-278.4(with)-270.5(denite)-275.1(functional)-278.6(impairment)-275.4(\(grade)-273.8(3\).)-270.5(Diabetes)]TJ T* [(mellitus)-512.6(status)-514.5(was)-506.2(classied)-514.2(according)-514.6(to)-509.2(the)-511.4(American)]TJ 0 -1.1174 TD [(Diabetes)-497.1(Association)-499.1(\(ADA\))-497.6(guidelines.)-495(Wound)-491.6(age)-495.2(was)]TJ 0 -1.1116 TD [(divided)-527.5(into)-523(4)-525.2(groups:)-526(less)-529.4(than)-524.1(8)-525.2(hours,)-521.3(8)]TJ /F11 1 Tf 19.1337 0 TD (*)Tj /F6 1 Tf 1.1692 0 TD [(16)-520.6(hours,)]TJ -20.303 -1.1116 TD (16)Tj /F11 1 Tf 1.1692 0 TD (*)Tj /F6 1 Tf 1.1692 0 TD [(24)-278.7(hours,)-279.4(and)-280.9(above)-284.3(24)-278.7(hours.)]TJ -1.3247 -1.1174 TD [(The)-673.8(physician)-668.9(level)-670.5(was)-673.3(classied)-675.5(as)-671.3(follows:)-672.2(non-)]TJ -1.0137 -1.1116 TD [(specialist,)-444.3(a)-440(practitioner)-437.6(who)-441.9(was)-437.1(trained)-442.2(in)-434.3(maxillofacial)]TJ T* [(surgery)-331.2(but)-326(not)-326(engaged)-328(in)-330.6(surgery;)-326.6(junior)-329.4(specialist,)-329.1(a)-324.8(sur-)]TJ 25.5097 67.9242 TD [(geon)-230.2(who)-228.8(had)-229.1(been)-231.4(engaged)-230.1(in)-232.7(surgical)-230(clinical)-231.7(work)-235.6(for)-227.9(two)]TJ 0 -1.1174 TD [(to)-301.8(ve)-309.6(years;)-308.3(and)-304(senior)-307.2(specialist,)-311.8(a)-307.5(surgeon)-302.4(who)-309.4(had)-304(been)]TJ 0 -1.1116 TD [(engaged)-281.9(in)-278.8(surgical)-287.6(clinical)-283.5(work)-281.7(for)-279.7(more)-283.2(than)-282.2(ve)-280.8(years.)]TJ 1.0137 -1.1116 TD [(Wo)12.8(und)-199.1(typ)13.8(es)-204.8(wer)12(e)-209.6(div)13.9(ide)12.7(d)-208.4(int)13.7(o)-208.4(int)13.7(ra)14(-or)14(al)-205.1(muc)11.6(osa)13(l)-208.6(wou)13.1(nds)14.2(,)]TJ -1.0137 -1.1116 TD [(extra-oral)-279.6(skin/lip)-274.1(wounds)-7.3(,)-274.1(and)-275.2(communicating)-279.9(wounds)-278(\(the)]TJ 0 -1.1174 TD [(wound)-277.1(penetrated)-280.8(from)-276.3(the)-275.3(extraoral)-278.5(skin/lip)-279.8(to)-278.8(the)-275.3(intraoral)]TJ 0 -1.1116 TD [(mucosa\).)-319.7(The)-316.7(trauma)-321.3(sites)-317.6(were)-318.6(divided)-320.2(into)-321.4(the)-315.6(lip,)-318(cheek,)]TJ T* [(chin,)-279.8(mandible,)-281(tongue,)-282(gum,)-284.4(and)-280.9(other)-283.2(parts.)]TJ /F10 1 Tf 8.9663 0 0 8.9663 310.8472 624.6423 Tm [(Statistical)-336.1(methods)]TJ /F6 1 Tf 9.843 0 0 9.843 320.8251 608.2014 Tm [(All)-373.1(data)-375.5(were)-376.2(analyzed)-376.5(with)-374.2(SPSS)-372.4(Statistics,)-379.7(version)-377.4(21)]TJ -1.0137 -1.1116 TD [(\(IBM)-403.7(Corp,)-406.3(Armonk,)-409.5(NY\).)-405.9(First,)-406.2(univariable)-407.6(analysis)-408.4(was)]TJ T* [(used)-471.9(to)-468.9(analyze)-479(gender,)-473.1(age,)-475.6(physical)-472(condition,)-475.7(diabetes)]TJ 0 -1.1174 TD [(mellitus,)-372.1(wound)-375(age,)-377.7(wound)-375(length,)-374.3(wound)-369.2(contamination,)]TJ 0 -1.1116 TD [(wound)-323.2(types)-329.1(\(intra-oral/extra-oral/communicating)-340.5(wounds\),)]TJ T* [(attending)-369.7(physician)-369.4(level,)-362.9(and)-367.3(anatomic)-370.9(site)-368.5(of)-365(injury.)-367.4(The)]TJ T* (Pearson)Tj /F11 1 Tf 3.5134 0 TD (w)Tj /F6 1 Tf 7.3823 0 0 6.5614 350.8723 546.8597 Tm (2)Tj 9.843 0 0 9.843 357.959 542.4944 Tm [(test)-351.2(was)-350.7(used)-351(\(p)]TJ /F7 1 Tf 6.8253 0 TD ()Tj /F6 1 Tf .72 0 TD [(0.05\).)-351.1(Statistically)-352.4(signicant)]TJ -12.3315 -1.1174 TD -.0168 Tc [(f)5.2(a)-1.8(cto)5.1(r)-.6(s)-317.2(i)-.7(n)-317.4(u)-.6(n)5.1(i)-.7(vari)5(ab)5.1(le)-318.6(anal)5(ys)5.3(is)-317.2(were)-318.6(fu)5.1(rt)5(her)-323.1(i)5(nclu)5.1(ded)-323.2(i)5(n)-323.2(b)5.1(in)5.1(ar)5.2(y)]TJ 0 -1.1116 TD [(l)5(o)-.6(g)5.1(i)-.8(st)5(ic)-255.2(r)5.2(e)-1.8(g)5.1(r)-.6(essi)5(on)-254(analy)5.1(s)-.4(i)5(s)-259.6(t)5(o)-254(id)5.1(en)5.1(ti)5(fy)-254(in)5.1(depend)5.1(en)5.1(t)-254.2(r)-.6(i)5(s)-.4(k)-254(f)-.6(act)5(o)-.6(r)5.2(s)-.4(.)]TJ /F4 1 Tf 8.9663 0 0 8.9663 310.8472 496.7999 Tm 0 Tc (Results)Tj /F6 1 Tf 9.843 0 0 9.843 320.8251 480.3589 Tm [(A)-405.1(total)-404.5(of)-405.3(3,276)-411(cases,)-409.5(2,147)-405.3(males)-406.4(and)-407.6(1,129)-405.3(females,)]TJ -1.0137 -1.1174 TD [(were)-387.7(eligible)-386(for)-389.1(inclusion)-385.7(in)-388.2(the)-384.7(study.)-383.3(In)-388.1(the)-384.7(univariable)]TJ 0 -1.1116 TD [(analysis,)-302.4(there)-307.4(was)-304.7(no)-301.7(signicant)-301.4(difference)-309.4(in)-301.8(the)-304.1(infection)]TJ T* [(rate)-202.7(between)-208(genders)-199.9(\(p)]TJ /F7 1 Tf 9.5726 0 TD (=)Tj /F6 1 Tf .72 0 TD [(0.364\),)-202.4(moreover,)-205.8(there)-203.8(was)-201(no)-203.8(sig-)]TJ -10.2926 -1.1116 TD [(nicant)-286.6(difference)-286.4(in)-284.5(the)-286.8(infection)-283.3(rate)-289(between)-288.7(wound)-282.8(ages)]TJ 0 -1.1174 TD (\(p)Tj /F7 1 Tf .9964 0 TD (=)Tj /F6 1 Tf .72 0 TD [(0.361\).)-242.7(American)-250.7(Society)-246.3(of)-244.1(Anesthesiologist)-251.3(grade)-243.9(\(p)]TJ /F7 1 Tf 22.0078 0 TD (<)Tj /F6 1 Tf -23.7242 -1.1116 TD [(0.001\),)-478.9(diabetes)-478.9(mellitus)-478.1(status)-479.9(\(p)]TJ /F7 1 Tf 14.5548 0 TD (<)Tj /F6 1 Tf .72 0 TD [(0.001\),)-473.1(wound)-478.7(length)]TJ -15.2747 -1.1116 TD (\(p)Tj /F7 1 Tf .9964 0 TD (<)Tj /F6 1 Tf .72 0 TD [(0.001\),)-242.7(wound)-236.8(contamination)-244.2(\(p)]TJ /F7 1 Tf 13.0227 0 TD (<)Tj /F6 1 Tf .72 0 TD [(0.001\),)-237(type)-241.8(of)-238.3(wound)]TJ -15.459 -1.1174 TD [(\(intra-oral/extra-oral/communicating)-962.5(wound\))-946.3(\(p)]TJ /F7 1 Tf 20.7349 0 TD (<)Tj /F6 1 Tf .72 0 TD (0.001\),)Tj -21.4549 -1.1116 TD [(physician)-352.1(level)-353.7(\(p)]TJ /F7 1 Tf 7.4991 0 TD (=)Tj /F6 1 Tf .72 0 TD [(0.038\),)-352.2(and)-350(injury)-346.7(site)-351.2(\(p)]TJ /F7 1 Tf 10.4711 0 TD (<)Tj /F6 1 Tf .72 0 TD [(0.001\))-348.7(were)]TJ -19.4102 -1.1116 TD [(substantially)-281.8(different)-283.1(\(Table)-286.7(1\).)]TJ 1.0137 -1.1174 TD [(Binary)-222(logistic)-223.4(analysis)-224.1(showed)-221.6(that)-224.7(there)-221(were)-226.4(substantial)]TJ -1.0137 -1.1116 TD [(differences)-310.4(in)-301.8(the)-309.9(following)-304.9(factors:)-304.9(age,)-308.6(1844)-305(years)-307.1(\(odds)]TJ T* [(ratio)-294.9([OR],)-297.7(2.2;)-294.9(95%)-298.1(condence)-296.6(interval)-299.5([CI],)-296.8(1.72.9\),)-299.1(44)]TJ 0 -1.1174 TD [(64)-215.3(years)-220.7(\(OR,)-221.7(3.1;)-214.2(95%)-223.2(CI,)-214(2.34.3\),)-218.5(and)]TJ /F7 1 Tf 16.4728 0 TD ()Tj /F6 1 Tf .5472 0 TD [(65)-221.1(years)-220.7(\(OR,)-216(2.6;)]TJ -17.0199 -1.1116 TD [(95%)-286.6(CI,)-294.6(1.74.1\);)-285.4(wound)-294.4(length:)-291.5(48)-164.6(cm)-292.6(\(OR,)-290.8(1.7;)-289.1(95%)-286.6(CI,)]TJ T* [(1.32.2\))-480(and)]TJ /F7 1 Tf 5.7367 0 TD (>)Tj /F6 1 Tf .5529 0 TD [(8)-168.1(c)0(m)-476.9(\(OR,)-480.9(2.4;)-479.2(95%)-476.7(CI,)-478.9(1.15.1\);)-475.4(type)-483.7(of)]TJ -6.2896 -1.1116 TD [(wound:)-433.8(intra-oral)-434.1(wound)-438.4(\(OR,)-434.8(1.6;)-433.1(95%)-436.3(CI,)-432.8(1.12.4\))-433.9(and)]TJ 0 -1.1174 TD [(communicating)-187.7(wound)-184.9(\(OR,)-181.4(3.2;)-185.4(95%)-182.9(CI,)-179.4(2.34.4\);)-187.5(physician)]TJ 0 -1.1116 TD [(level:)-291.5(junior)-289.1(specialist)-291.1(\(OR,)-290.8(1.6;)-289.1(95%)-286.6(CI,)-288.9(1.22.2\);)-291.1(sites:)-290(lip)]TJ T* [(\(OR,)-348.4(3.7;)-352.4(95%)-350(CI,)-352.2(1.112.0\))-348.6(and)-350(cheek)-354.6(\(OR,)-354.2(4.7;)-346.7(95%)-349.9(CI,)]TJ 0 -1.1174 TD (2.317.1\).)Tj 1.0137 -1.1116 TD [(The)-616.2(above)-624.1(factors)-626.2(were)-618.1(independen)-8.9(t)-617.5(risk)-620.6(factors)-626.2(for)]TJ -1.0137 -1.1116 TD [(infection)-387(\(Table)-390.4(2\).)-385.7(Binary)-383.3(logistic)-390.4(regression)-387.4(analysis)-391.2(did)]TJ 0 -1.1174 TD [(not)-567.9(show)-569.5(a)-566.7(signicant)-572.1(relationship)-574.5(between)-570.9(ASA)-569.3(grade)]TJ 0 -1.1116 TD (\(p)Tj /F7 1 Tf .9964 0 TD (=)Tj /F6 1 Tf .72 0 TD [(0.531\),)-283(diabetes)-288.8(mellitus)-288(\(p)]TJ /F7 1 Tf 11.2141 0 TD (=)Tj /F6 1 Tf .72 0 TD [(0.111\),)-283.1(wound)-282.8(contamina-)]TJ -13.6505 -1.1116 TD [(tion)-281.1(\(p)]TJ /F7 1 Tf 2.8395 0 TD (=)Tj /F6 1 Tf .72 0 TD [(0.155\),)-283.1(and)-280.9(infection)-283.3(\(Table)-280.9(2\).)]TJ /F4 1 Tf 8.9663 0 0 8.9663 310.8472 171.6661 Tm (Discussion)Tj /F6 1 Tf 9.843 0 0 9.843 320.8251 155.2252 Tm [(Oral)-478.8(and)-476.8(maxillofacial)-481.6(STI)-482.4(is)-474.4(a)-480.3(common)-476.8(and)-482.5(frequent)]TJ -1.0137 -1.1174 TD [(disease)-736.7(in)-739.6(the)-736.1(emergency)-741.5(department)-735.9(of)-739.4(stomatology.)]TJ 0 -1.1116 TD [(Seventy)-401.7(percent)-397.2(of)-399.6(STIs)-402.6(are)-397.3(penetrating)-401.9(wounds)-404.7(and)-396.1(need)]TJ T* [(sutures)-325.4([1].)-323.5(There)-325.8(have)-323.5(been)-323.5(few)-327.8(reports)-325.5(on)-319(risk)-326.8(factors)-326.7(for)]TJ 0 -1.1174 TD [(infection)-306.3(after)-307.4(suturing)-302.6(penetrating)-309.7(wounds)-301(of)-307.4(maxillofacial)]TJ 0 -1.1116 TD [(STIs.)-216(Similar)-211.9(studies)-216.1(have)-214.1(mostly)-215.2(focused)-217.2(on)-215.3(body)-211.8(laceration)]TJ T* [(infection)-312.1(and)-304(maxillofacial)-314.6(animal)-309.9(bite)-311.1(infection)-312.1([36].)-308.4(The)]TJ 0 -1.1174 TD [(results)-262.1(of)-267.1(these)-261.2(studies)-267.9(on)-261.4(the)-263.8(relation)-264.9(between)-265.6(age,)-268.2(physical)]TJ 0 -1.1116 TD [(condition,)-372(wound)-375(length,)-374.3(wound)-375(pollution,)-376.7(wound)-375(age)-374.3(and)]TJ T* [(infection)-283.3(risk)-280.8(are)-282.1(not)-279.9(consistent.)]TJ /F4 1 Tf 8.9663 0 0 8.9663 59.7543 749.7069 Tm [(RISK)-335.9(FOR)-334(INFECTION)-337.6(OF)-337.5(MAXILLOFACIAL)-334.4(STIS)-29653.1(299)]TJ ET endstream endobj 33 0 obj <>stream ht PTe>upnԧ~W$@| */S@0 .+Ps wy 2|E #X+91&Ǵܙ33p=LkM-\p$Axt'pqca톺]*5<"Bz ;\M]u$el*@?7Wn.1\ uҏ-p8 6{~y} c,ނz%iCIt'ywRP:ʪ+TjЉ__iQci&Qρ.: _ y!aŠެV}.qڲm͵|? A}=31 搯zb.G^T?8# )+I@uH2 y!d8vRыϖڪ&z@G_Y /tyP3+,O* "~mwkh 5lгຠO+ۗGxKr$yxT'U1_? e`Skŭ=ƶٚOgc)#fOOKt9T<cp:V߱zߕWZQ|b_b1%H%0^70 ՛Rvu{&՛ܷ{_L]g` I086˙rZ+_z7瑩p_=7YX'%}E~ [>p6k>stream /GS1 gs BT /F6 1 Tf 9.843 0 0 9.843 72 188.107 Tm 0 0 0 rg 0 Tc 0 Tw [(Several)-408.6(studies)-411.9(have)-409.9(shown)-409.4(that)-409(increased)-417.6(age)-408.8(is)-411.1(a)-405.4(risk)]TJ -1.0137 -1.1116 TD [(factor)-320(for)-320(an)-320.1(increase)-318.6(in)-319.1(laceration)-321.3(infection)-323.6([7,8].)-316.5(Children)]TJ T* [(are)-195.7(more)-191.1(prone)-196.7(to)-192.4(maxillofacial)-199.4(laceration,)-198(and)-194.5(their)-191.2(infection)]TJ 0 -1.1174 TD [(rate)-185.4(is)-180.7(lower)-180.4(than)-184.2(that)-184.4(of)-180.7(adults.)-184.1(In)-180.7(this)-183(study,)-181.7(it)-181(was)-183.7(also)-178.3(found)]TJ 0 -1.1116 TD [(that)-265(adults)-267(were)-266.8(more)-266(likely)-267.3(to)-267.3(be)-262.5(infected)-271.7(than)-264.9(children)-264.8(and)]TJ T* [(adolescents)-224(under)-219.7(the)-223.5(age)-218.7(of)-215.3(18.)-218.7(The)-224.5(mechanism)-223.1(of)-215.3(the)-223.5(effect)]TJ 0 -1.1174 TD [(of)-272.9(age)-270.6(on)-267.1(infection)-277.5(was)-270.1(not)-268.4(clear.)-277.5(This)-270.5(may)-270.6(be)-268.3(related)-276.4(to)-267.3(the)]TJ 0 -1.1116 TD [(inammatory)-322.2(response)-316(affected)-324.6(by)-313.2(age)-316.7([9])-320(and)-315.5(may)-316.7(also)-316.5(be)]TJ T* [(related)-328.2(to)-330.6(hypoxia)-325.8(caused)-332.4(by)-324.7(insufcient)-331.2(local)-330.6(blood)-328.2(perfu-)]TJ 0 -1.1174 TD [(sion)-315.4(in)-313.4(elderly)-309.8(patients)-316.6([10].)-313(The)-316.7(inuence)-317.5(of)-307.4(physical)-316.5(con-)]TJ 0 -1.1116 TD [(dition)-237.4(on)-232.6(STI)-234.7(infection)-237.2(is)-232.5(controversial)-236.8([11,12].)-238(In)-232.6(this)-234.9(study,)]TJ T* [(the)-379(increased)-377.3(infection)-381.2(rate)-375.4(caused)-378.5(by)-370.8(age)-380(seemed)-379.8(to)-370.9(have)]TJ T* [(nothing)-249.9(to)-250(do)-249.9(with)-253.2(the)-252.3(physical)-253.1(condition)-247.6(aggravated)-257.7(by)-249.9(age.)]TJ 25.504 13.3568 TD [(With)-254.6(facial)-258(injury)-248.7(caused)-257.6(by)-249.9(high-impact)-252.2(trauma,)-255.6(those)-254.3(aged)]TJ 0 -1.1116 TD [(older)-300.5(than)-299.4(60)-295.9(years)-301.3(with)-293.5(underlying)-300.4(diseases,)-303.3(including)-299.5(dia-)]TJ T* [(betes)-272.7(mellitus,)-268.4(showed)-267.6(a)-267.2(higher)-267.1(proportion)-264.6(of)-267.1(infection)-266([13].)]TJ 0 -1.1174 TD [(Howev)-8.4(er,)-502.1(in)-497.7(this)-505.6(study,)-498.5(with)-500.9(mild)-507(trauma)-499.8(such)-506.5(as)-498.5(STIs,)]TJ 0 -1.1116 TD [(patients)-385.7(with)-379.9(underlying)-381(diseases)-380.5(\(ASA)-380.3(grade)-382.2(2/3\))-378.9(did)-383.6(not)]TJ T* [(show)-523.5(a)-520.6(higher)-526.2(infection)-525.2(rate.)-522.9(Notably,)-520.3(the)-523(nding)-519.2(as)-521.5(to)]TJ 0 -1.1174 TD [(whether)-419.9(diabetes)-415.5(mellitus)-420.5(increased)-417.6(infection)-415.8(of)-411.1(STIs)-414.2(was)]TJ 0 -1.1116 TD [(different)-237(in)-232.7(the)-235(literature)-233.8([3,8,14].)-235.7(Diabetes)-232.1(mellitus)-236.2(was)-235.5(also)]TJ T* [(not)-285.7(a)-278.7(risk)-280.8(factor)-285.5(for)-279.7(infection)-283.3(in)-278.8(this)-280.9(study.)]TJ 1.0137 -1.1174 TD [(Regarding)-537.5(more)-530.9(serious)-532.7(maxillofacial)-539.2(trauma,)-532.1(such)-529.5(as)]TJ -1.0137 -1.1116 TD [(fractures,)-345(delay)-336.3(to)-330.6(theater)-339.7(could)-335.1(increase)-341.7(the)-332.9(post-operative)]TJ T* [(infection)-410(rate)-410([15].)-405.2(However,)-412.6(for)-406.4(STIs,)-406.1(the)-407.8(concept)-408.8(of)-411.1(the)]TJ T* [(golden)-486(period)-485.9(has)-488.1(been)-484.8(gradually)-484.8(abandoned)-485.7([1619].)-483.4(In)]TJ ET 62.022 709.512 490.167 .22681 re f 62.022 243.666 490.167 .22675 re f 62.022 690.803 490.167 .28345 re f BT /F9 1 Tf 9.845 0 0 9.845 149.0456 725.1588 Tm (Table)Tj /F6 1 Tf 3.0002 0 TD (1.)Tj /F9 1 Tf 1.2496 0 TD [(Cases)-333.7(and)-332(Maxillofacial)-336.8(Soft)-333(Tissue)-336.3(Injury)-336.3(Characteristics)]TJ 1.8255 -1.0135 TD [(and)-337.8(Their)-329.9(Association)-340.6(with)-328.9(Infection)-340.6(Rate)]TJ /F6 1 Tf -2.5626 -1.8427 TD (n)Tj /F12 1 Tf .835 0 TD [(\(%\))-4668.4(Non-infection)-339.4(\(%\))-2831.4(Infection)-334.3(\(%\))]TJ /F11 1 Tf 25.758 0 TD (w)Tj /F6 1 Tf 7.3837 0 0 6.5625 450.8219 701.4045 Tm (2)Tj 9.845 0 0 9.845 505.1904 697.0392 Tm (p)Tj -45.0145 -1.8946 TD (Gender)Tj 1.002 -1.0135 TD [(Male)-7458.9(2,147)-335.6(\()-997.2(65.5\))-4009.5(1,827)-335.6(\(85.1\))-4586.4(320)-337(\(14.9\))-4413.6(0.825)-3381.8(0.364)]TJ T* [(Female)-6563.8(1,129)-335.6(\()-997.2(34.5\))-4763.9(974)-331.2(\(86.3\))-4586.4(155)-337(\(13.7\))]TJ -1.002 -1.0077 TD (Age)Tj 7.3837 0 0 6.5625 78.463 652.8754 Tm (a)Tj /F7 1 Tf 9.845 0 0 9.845 71.8866 638.5321 Tm (<)Tj /F6 1 Tf .5528 0 TD [(18)-163.2(y)-7302.8(1,474)-335.6(\()-997.2(45.0\))-4009.5(1,357)-335.6(\(92.1\))-4586.4(117)-337(\()-502(7.9\))-3409.6(111.486)]TJ /F7 1 Tf 42.308 0 TD (<)Tj /F6 1 Tf .5528 0 TD (0.001)Tj -43.4137 -1.0135 TD [(1844)-166.2(y)-6352.7(1,121)-335.6(\()-997.2(34.2\))-4763.9(928)-331.2(\(82.8\))-4586.4(193)-337(\(17.2\))]TJ T* [(4564)-166.2(y)-7101.3(444)-337(\()-997.2(13.6\))-4763.9(333)-331.2(\(75.0\))-4586.4(111)-337(\(25.0\))]TJ /F7 1 Tf 0 -1.0077 TD ()Tj /F6 1 Tf .5528 0 TD [(65)-163.2(y)-8051.4(237)-337(\()-1498.2(7.2\))-4762.9(183)-331.2(\(77.2\))-5087.4(54)-336(\(22.8\))]TJ -1.5548 -1.0135 TD [(ASA)-332.7(grade)]TJ 1.002 -1.0135 TD [(Grade)-336.4(1)-6237.5(2,993)-335.6(\()-997.2(91.4\))-4009.5(2,592)-335.6(\(86.6\))-4586.4(401)-337(\(13.4\))-3912.6(35.402)]TJ /F7 1 Tf 42.8609 0 TD (<)Tj /F6 1 Tf .5528 0 TD (0.001)Tj -43.4137 -1.0135 TD [(Grade)-336.4(2)-6986.1(226)-337(\()-1498.2(6.9\))-4762.9(164)-331.2(\(72.6\))-5087.4(62)-336(\(27.4\))]TJ 0 -1.0077 TD [(Grade)-336.4(3)-7487.1(5)0(7)-336(\()-1498.2(1.7\))-5258.1(45)-336(\(78.9\))-5087.4(12)-336(\(21.1\))]TJ -1.002 -1.0135 TD [(Diabetes)-340.7(mellitus)]TJ 1.002 -1.0135 TD [(No)-8300.9(3,198)-335.6(\()-997.2(97.6\))-4009.5(2,748)-335.6(\(84.9\))-4586.4(450)-337(\(14.1\))-3912.6(19.856)]TJ /F7 1 Tf 42.8609 0 TD (<)Tj /F6 1 Tf .5528 0 TD (0.001)Tj -43.4137 -1.0135 TD [(Yes)-9218.5(78)-336(\()-1498.2(2.4\))-5258.1(53)-336(\(67.9\))-5087.4(25)-336(\(32.1\))]TJ -1.002 -1.0077 TD [(Wound)-335.3(age)]TJ /F7 1 Tf 1.002 -1.0135 TD (<)Tj /F6 1 Tf .5528 0 TD [(8)-162.2(h)-7803.8(2,984)-335.6(\(2984\))-4756.7(2,552)-335.6(\(85.5\))-4586.4(432)-337(\(14.5\))-4413.6(3.203)-3381.8(0.361)]TJ -.5528 -1.0135 TD [(816)-165.2(h)-7602.3(175)-337(\()-1498.2(5.3\))-4762.9(153)-331.2(\(87.4\))-5087.4(22)-336(\(12.6\))]TJ 0 -1.0077 TD [(1624)-166.2(h)-7602.3(2)0(8)-336(\()-1498.2(0.9\))-5258.1(25)-336(\(89.3\))-5588.4(3)-335(\(10.7\))]TJ /F7 1 Tf 0 -1.0135 TD (>)Tj /F6 1 Tf .5528 0 TD [(24)-163.2(h)-8552.4(8)0(9)-336(\()-997.2(89\))-6009.1(71)-336(\(79.8\))-5087.4(18)-336(\(20.2\))]TJ -1.5548 -1.0135 TD [(Wound)-335.3(length)]TJ /F7 1 Tf 1.002 -1.0135 TD (<)Tj /F6 1 Tf .5528 0 TD [(4)-162.2(c)0(m)-7075.8(2,732)-335.6(\()-997.2(83.4\))-4009.5(2,383)-335.6(\(87.2\))-4586.4(349)-337(\(12.8\))-3912.6(40.701)]TJ /F7 1 Tf 42.308 0 TD (<)Tj /F6 1 Tf .5528 0 TD (0.001)Tj -43.4137 -1.0077 TD [(48)-164.2(cm)-7375.3(508)-337(\()-997.2(15.5\))-4763.9(394)-331.2(\(77.6\))-4586.4(114)-337(\(22.4\))]TJ /F7 1 Tf 0 -1.0135 TD (>)Tj /F6 1 Tf .5528 0 TD [(8)-162.2(c)0(m)-8325.4(3)0(6)-336(\()-1498.2(1.1\))-5258.1(24)-336(\(66.7\))-5087.4(12)-336(\(33.3\))]TJ -1.5548 -1.0135 TD [(Wound)-335.3(contamination)]TJ 1.002 -1.0135 TD [(No)-8300.9(2,437)-335.6(\()-997.2(74.4\))-4009.5(2,123)-335.6(\(87.1\))-4586.4(314)-337(\(12.9\))-3912.6(20.012)]TJ /F7 1 Tf 42.8609 0 TD (<)Tj /F6 1 Tf .5528 0 TD (0.001)Tj -43.4137 -1.0077 TD [(Yes)-8717.5(839)-337(\()-997.2(25.6\))-4763.9(678)-331.2(\(80.8\))-4586.4(161)-337(\(19.2\))]TJ -1.002 -1.0135 TD (Communication)Tj 1.002 -1.0135 TD [(Extra-oral)-6198.4(980)-337(\()-997.2(29.9\))-4763.9(902)-331.2(\(92.0\))-5087.4(78)-336(\()-502(8.0\))-3409.6(113.439)]TJ /F7 1 Tf 42.8609 0 TD (<)Tj /F6 1 Tf .5528 0 TD (0.001)Tj -43.4137 -1.0077 TD [(Intra-oral)-5730.8(1,314)-335.6(\()-997.2(40.1\))-4009.5(1,156)-335.6(\(88.0\))-4586.4(158)-337(\(12.0\))]TJ 0 -1.0135 TD [(Communication)-3802.4(982)-337(\()-997.2(30.0\))-4763.9(743)-331.2(\(75.7\))-4586.4(239)-337(\(24.3\))]TJ -1.002 -1.0135 TD [(Attending)-333.9(physician)-339.7(level)]TJ 1.002 -1.0135 TD [(Senior)-335.3(specialist)-2835.5(1,239)-335.6(\()-997.2(37.8\))-4009.5(1,061)-335.6(\(85.6\))-4586.4(178)-337(\(14.4\))-4413.6(6.520)-3381.8(0.038)]TJ 0 -1.0077 TD [(Junior)-334.2(specialist)-3699.2(517)-337(\()-997.2(15.8\))-4763.9(424)-331.2(\(82.0\))-5087.4(93)-336(\(18.0\))]TJ 0 -1.0135 TD [(Non-specialist)-3732.8(1,520)-335.6(\()-997.2(46.4\))-4009.5(1,316)-335.6(\(86.6\))-4586.4(204)-337(\(13.4\))]TJ -1.002 -1.0135 TD (Sites)Tj 1.002 -1.0135 TD [(Tongue)-7707.4(63)-336(\()-1498.2(1.9\))-5258.1(60)-336(\(95.2\))-5588.4(3)-335(\()-502(4.8\))-3910.6(52.191)]TJ /F7 1 Tf 42.8609 0 TD (<)Tj /F6 1 Tf .5528 0 TD (0.001)Tj -43.4137 -1.0077 TD [(Gum)-8268.5(173)-337(\()-1498.2(5.3\))-4762.9(164)-331.2(\(94.8\))-5588.4(9)-335(\()-502(5.2\))]TJ 0 -1.0135 TD [(Mandible)-6927.4(33)-336(\()-1498.2(1.0\))-5258.1(31)-336(\(93.9\))-5588.4(2)-335(\()-502(6.1\))]TJ T* [(Chin)-8320.5(323)-337(\()-1498.2(9.9\))-4762.9(294)-331.2(\(91.0\))-5087.4(29)-336(\()-502(9.0\))]TJ 0 -1.0077 TD [(Cheek)-7707.5(121)-337(\()-1498.2(3.7\))-5258.1(95)-336(\(78.5\))-5087.4(26)-336(\(21.5\))]TJ 0 -1.0135 TD [(Lip)-8123.9(2,399)-335.6(\()-997.2(73.2\))-4009.5(2,001)-335.6(\(83.4\))-4586.4(398)-337(\(16.6\))]TJ T* [(Others)-7603.5(164)-337(\()-1498.2(5.0\))-4762.9(156)-331.2(\(95.1\))-5588.4(8)-335(\()-502(4.9\))]TJ -1.002 -1.0135 TD [(Total)-8397.8(3,276)-335.6(\()-496.2(100.0\))-4010.5(2,801)-335.6(\(85.5\))-4586.4(475)-337(\(14.5\))]TJ 8.7511 0 0 8.7511 70.0157 231.8173 Tm (ASA)Tj /F7 1 Tf 2.1508 0 TD (=)Tj /F6 1 Tf .7191 0 TD [(American)-334.7(Society)-334.8(of)-333.1(Anesthesiologists;)-332.4(SD)]TJ /F7 1 Tf 17.9062 0 TD (=)Tj /F6 1 Tf .7191 0 TD [(standard)-332.1(deviation.)]TJ 6.5633 0 0 5.8334 70.0157 226.7716 Tm (a)Tj 8.7511 0 0 8.7511 72.9637 222.8598 Tm [(Age:)-334.4(average)]TJ /F7 1 Tf 5.5649 0 TD ()Tj /F6 1 Tf .7191 0 TD [(SD:)-334.2(5.4)]TJ /F7 1 Tf 3.2975 0 TD ()Tj /F6 1 Tf .7191 0 TD [(22.7)-336(years)-330.4(old.)-334.8(Maximum,)-330.1(90)-334.5(years)-336.8(old;)-329.7(minimum,)-334.5(1)-329.2(year)-333.1(old.)]TJ /F4 1 Tf 8.9663 0 0 8.9663 62.022 749.6502 Tm (300)Tj 48.8255 0 TD [(GUO)-331.4(ET)-338.7(AL.)]TJ ET endstream endobj 42 0 obj <>stream /GS1 gs BT /F6 1 Tf 9.843 0 0 9.843 59.7543 286.7527 Tm 0 0 0 rg 0 Tc 0 Tw [(many)-225.7(studies,)-219.5(it)-221.3(was)-224(considered)-227.5(that)-218.9(wound)-225.3(age)-218.7(had)-223.3(no)-221.1(effect)]TJ 0 -1.1116 TD [(on)-445.7(the)-448.1(infection)-444.6(rate)-450.3(of)-439.9(laceration)-453.8([18,19].)-445.4(Although)-441.9(it)-446(is)]TJ T* [(important)-260.3(to)-255.8(see)-258.9(a)-255.7(physician)-260(as)-256.6(soon)-257.6(as)-256.6(possible)-263.3(after)-255.6(trauma)]TJ 0 -1.1174 TD [(to)-589.8(reduce)-591.8(the)-592.1(infection)-588.6(rate)-594.3([17],)-589.5(in)-584.1(everyday)-594(practice,)]TJ 0 -1.1116 TD [(wounds)-289.5(are)-293.6(sutured)-291(regardless)-290.6(of)-290.2(the)-292.6(elapsed)-287.6(time)-289.3([18].)-290(It)-290.3(is)]TJ T* [(recommended)-445.4(that)-443.6(head)-438.7(and)-436.4(neck)-444.5(STIs)-437.2(be)-441.1(sutured)-440.8(within)]TJ T* [(24)-428.4(hours)-425.7(of)-428.4(occurrence)-431.5([20].)-428.2(In)-422.6(this)-424.9(study,)-429.3(there)-428.4(were)-428(no)]TJ 0 -1.1174 TD [(differences)-235.5(in)-227(infection)-231.5(between)-231.1(different)-231.3(wound)-231(age)-224.5(groups.)]TJ 0 -1.1116 TD [(Notably,)-266.9(the)-258(infection)-266(rate)-260.3(of)-261.4(maxillofacial)-268.5(STIs)-258.6(with)-264.7(an)-262.5(age)]TJ T* [(of)-255.6(over)-247.4(24)-255.6(hours)-247.2(was)-252.8(not)-251.1(different)-254.3(from)-253.2(that)-253.5(for)-250.9(other)-254.4(wound)]TJ 0 -1.1174 TD [(ages.)-516.8(Therefore,)-519(we)-516.8(suggest)-515.5(that)-518.4(even)-513.6(if)-514.9(the)-517.2(penetrating)]TJ 0 -1.1116 TD [(wound)-323.2(age)-316.7(exceeds)-323.2(24)-319(hours,)-319.7(debridement)-328.1(and)-315.5(suturing)-319.9(are)]TJ T* [(valuable)-283.3(if)-284.5(there)-284.4(is)-278.6(no)-278.7(serious)-285(infection.)]TJ 1.0137 -1.1174 TD [(Visible)-338.2(contamination,)-339.8(injury)-335.1(deeper)-338.4(than)-334(the)-338.7(subcutane-)]TJ -1.0137 -1.1116 TD [(ous)-342.9(tissue,)-339.4(and)-338.5(the)-338.7(presence)-341.5(of)-336.2(a)-342.1(foreign)-337.2(body)-338.5(are)-339.7(all)-344.5(asso-)]TJ T* [(ciated)-246.5(with)-247.4(an)-239.5(increased)-250.6(risk)-240.4(of)-244.1(infection)-248.7([8].)-242.8(A)-243.9(foreign)-245.1(body)]TJ 0 -1.1174 TD [(and)-730.2(devitalized)-737.3(tissue)-727.6(or)-733.6(tissue)-727.6(of)-733.7(uncertain)-727.8(viability)]TJ 0 -1.1116 TD [(increases)-463.5(the)-453.9(likelihood)-456.2(of)-451.4(an)-452.6(inammato)-9(ry)-451.4(response)-454.2(and)]TJ T* [(infection)-456.1([20,21].)-451.1(However,)-458.7(some)-450.1(parts)-455.8(of)-451.4(the)-453.8(body)-453.7(have)]TJ T* [(complex)-506.7(tissue)-503(levels)-504.3([3,20],)-501.9(which)-503(effect)-505.5(the)-499.9(operators)]TJ 0 -1.1174 TD [(exploration)-481.3(and)-476.8(cleanliness)-477.5(of)-474.5(foreign)-475.5(bodies.)-477.7(Soft)-476.6(tissue)]TJ 0 -1.1116 TD [(infection)-438.8(in)-440.1(the)-436.6(maxillofacial)-441.3(region,)-437.5(which)-439.6(has)-436.2(thin,)-434.3(soft)]TJ 25.5097 23.3786 TD [(tissue,)-304.8(is)-307.4(more)-306.3(conducive)-307.3(to)-307.6(the)-309.9(exploration)-308.5(and)-304(removal)-310.9(of)]TJ 0 -1.1116 TD [(foreign)-348.8(bodies)-353.3(and)-350(visible)-354.6(contamination.)-357.1(Additionally,)-353.4(the)]TJ T* [(rich)-184.2(blood)-184.2(supply)-190.9(of)-180.7(maxillofacial)-193.6(soft)-182.9(tissues)-192.9(reduces)-183.8(the)-188.9(rate)]TJ 0 -1.1174 TD [(of)-307.4(infection)-317.9([8].)-311.9(In)-313.2(this)-309.7(study,)-314.1(although)-309.7(the)-315.6(infection)-312.1(rate)-317.8(of)]TJ 0 -1.1116 TD [(wounds)-352.9(with)-351.1(foreign)-354.5(bodies)-359.1(and)-350(visible)-354.6(contamination)-359.4(was)]TJ T* [(different)-248.6(from)-247.5(that)-242(of)-249.8(uncontaminated)-246.3(wounds)-249.2(in)-244.2(univariable)]TJ T* [(analysis,)-440.7(binary)-434.1(logistic)-442.3(analysis)-437.2(did)-435.4(not)-435.4(nd)-435.1(visible)-441(con-)]TJ 0 -1.1174 TD [(tamination)-447.1(to)-445.8(be)-446.9(an)-452.6(independent)-447.9(risk)-447.8(factor)-446.7(for)-446.7(infection.)]TJ 0 -1.1116 TD [(When)-388(the)-390.5(wound)-392.3(was)-391(debrided)-391.4(according)-393.6(to)-388.2(the)-390.5(treatment)]TJ T* [(standard,)-325.5(the)-321.4(infection)-329.4(rate)-323.6(was)-327.7(not)-320.2(affected)-330.3(by)-319(the)-327.1(original)]TJ 0 -1.1174 TD [(pollution)-281.1(state.)]TJ 1.0137 -1.1116 TD [(The)-357(bacterial)-360.5(wound)-357.7(ora)-356.7(and)-355.8(the)-355.9(local)-359.4(condition)-357(of)-359.3(the)]TJ -1.0137 -1.1116 TD [(wound)-461.4(are)-466.4(inter-related.)-466.3(Wound)-462.8(infection)-467.6(is)-462.9(the)-459.6(result)-468.6(of)]TJ 0 -1.1174 TD [(the)-258(relation)-264.9(between)-265.6(wound)-259.8(condition)-264.9(and)-257.9(bacterial)-268.3(invasion)]TJ 0 -1.1116 TD [([12].)-578(Most)-575.5(bacteria)-583.9(isolated)-581.5(from)-575.8(infected)-582.7(elds)-576.7(persist)]TJ T* [(around)-422.4(cutaneous)-422.3(elds)-421.1(and)-419.2(pharyngeal)-423.5(bacteria)-422.6([22].)-422.5(For)]TJ 0 -1.1174 TD [(clean-contaminated)-208.2(wounds,)-206.6(the)-200.4(post-operative)-209.1(infection)-202.7(rate)]TJ 0 -1.1116 TD [(may)-184.2(reach)-193.3(10%)-182.9([23].)-186.3(The)-190(intra-oral)-192.2(environment)-188.7(is)-186.4(a)-186.6(bacterial)]TJ T* [(environment.)-215.2(Although)-217.3(wounds)-214.6(may)-213(be)-216.5(debrided)-218.6(and)-211.8(sutured)]TJ T* [(in)-250(time,)-252.4(the)-258(infection)-254.5(rate)-254.5(of)-249.8(intra-oral)-255.5(wounds)-255(is)-249.8(higher)-255.5(than)]TJ 0 -1.1174 TD [(that)-512.7(of)-514.8(extra-oral)-515.8(skin)-516.9(wounds.)-511.8(Research)-521.1(on)-509.1(craniofacial)]TJ 0 -1.1116 TD [(reconstructive)-440.7(procedures)-434.7(found)-431.7(that)-437.8(implantation)-432.1(through)]TJ ET 59.754 709.512 490.167 .22681 re f 59.754 333.298 490.167 .28345 re f 59.754 690.803 490.167 .28345 re f BT /F9 1 Tf 9.845 0 0 9.845 124.611 725.1588 Tm (Table)Tj /F6 1 Tf 3.0002 0 TD (2.)Tj /F9 1 Tf 1.2496 0 TD [(Cases)-339.4(and)-332(Maxillofacial)-336.8(Soft)-333(Tissue)-336.3(Injury)-330.6(Characteristics)-339.1(Retained)]TJ -4.0252 -1.0135 TD [(in)-337.3(the)-332.4(Logistic)-337.2(Regression)-334(Model)-333.6(That)-334.4(Are)-332(Associated)-338.3(with)-328.9(Wound)-337.3(Infection)]TJ /F6 1 Tf 4.7911 -1.8427 TD (n)Tj /F12 1 Tf .835 0 TD [(\(%\))-3919.8(Infection)-334.3(\(%\))-2583.8(Non-infection)-339.4(\(%\))]TJ /F6 1 Tf 24.4968 0 TD (p)Tj /F12 1 Tf 4.3592 0 TD [(OR)-332.2(\(95%)-333.2(CI\))]TJ /F6 1 Tf -41.2945 -1.8946 TD (Age)Tj /F7 1 Tf 1.002 -1.0135 TD (<)Tj /F6 1 Tf .5528 0 TD [(18)-163.2(y)-7055.2(1,474)-335.6(\(45.0\))-2783.9(1,357)-335.6(\(92.1\))-4338.7(117)-331.2(\()-502(7.9\))]TJ /F7 1 Tf 34.2288 0 TD (<)Tj /F6 1 Tf .5528 0 TD [(0.001)-2581.4(1.0)]TJ -35.3344 -1.0135 TD [(18-44)-166.2(y)-6272.1(1,121)-335.6(\(34.2\))-3532.6(928)-337(\(82.8\))-4338.7(193)-331.2(\(17.2\))]TJ /F7 1 Tf 34.7816 0 TD (<)Tj /F6 1 Tf .5528 0 TD [(0.001)-2581.4(2.2)-333.6(\(1.7-)-502.6(2.9\))]TJ -35.3344 -1.0077 TD [(4564)-166.2(y)-6853.7(444)-337(\(13.6\))-3532.6(333)-337(\(75.0\))-4338.7(111)-331.2(\(25.0\))]TJ /F7 1 Tf 34.7816 0 TD (<)Tj /F6 1 Tf .5528 0 TD [(0.001)-2581.4(3.1)-333.6(\(2.3)-502.6(4.3\))]TJ /F7 1 Tf -35.3344 -1.0135 TD ()Tj /F6 1 Tf .5528 0 TD [(65)-163.2(y)-7803.8(237)-337(\()-496.2(7.2\))-3536.3(183)-337(\(77.2\))-4839.7(54)-330.2(\(22.8\))]TJ /F7 1 Tf 34.2288 0 TD (<)Tj /F6 1 Tf .5528 0 TD [(0.001)-2581.4(2.6)-333.6(\(1.7)-502.6(4.1\))]TJ -36.3364 -1.0135 TD [(ASA)-338.4(grade)]TJ 1.002 -1.0135 TD [(Grade)-336.4(1)-5989.9(2,993)-335.6(\(91.4\))-2783.9(2,592)-335.6(\(86.6\))-4338.7(401)-331.2(\(13.4\))-4690(0.531)-2581.4(1.0)]TJ 0 -1.0077 TD [(Grade)-336.4(2)-6738.5(226)-337(\()-496.2(6.9\))-3536.3(164)-337(\(72.6\))-4839.7(62)-330.2(\(27.4\))-4690(0.399)-2581.4(1.2)-333.6(\(0.8)-502.6(1.8\))]TJ 0 -1.0135 TD [(Grade)-336.4(3)-7239.5(5)0(7)-336(\()-496.2(1.7\))-4037.3(45)-336(\(78.9\))-4839.7(12)-330.2(\(21.1\))-4690(0.671)-2581.4(0.8)-333.6(\(0.4)-502.6(1.8\))]TJ -1.002 -1.0135 TD [(Diabetes)-340.7(mellitus)]TJ 1.002 -1.0135 TD [(No)-8053.2(3,198)-335.6(\(97.6\))-2783.9(2,748)-335.6(\(84.9\))-4338.7(450)-331.2(\(14.1\))-9521.4(1.0)]TJ 0 -1.0077 TD [(Yes)-8970.8(78)-336(\()-496.2(2.4\))-4037.3(53)-336(\(67.9\))-4839.7(25)-330.2(\(32.1\))-4690(0.111)-2581.4(1.6)-333.6(\(0.9)-502.6(3.0\))]TJ -1.002 -1.0135 TD [(Wound)-335.3(length)]TJ /F7 1 Tf 1.002 -1.0135 TD (<)Tj /F6 1 Tf .5528 0 TD [(4)-168(c)0(m)-6822.4(2,732)-335.6(\(83.4\))-2783.9(2,383)-335.6(\(87.2\))-4338.7(349)-331.2(\(12.8\))]TJ /F7 1 Tf 34.2288 0 TD (<)Tj /F6 1 Tf .5528 0 TD [(0.001)-2581.4(1.0)]TJ -35.3344 -1.0135 TD [(48)-164.2(cm)-7127.6(508)-337(\(15.5\))-3532.6(394)-337(\(77.6\))-4338.7(114)-331.2(\(22.4\))]TJ /F7 1 Tf 34.7816 0 TD (<)Tj /F6 1 Tf .5528 0 TD [(0.001)-2581.4(1.7)-333.6(\(1.3)-502.6(2.2\))]TJ /F7 1 Tf -35.3344 -1.0077 TD (>)Tj /F6 1 Tf .5528 0 TD [(8)-168(c)0(m)-8072(3)0(6)-336(\()-496.2(1.1\))-4037.3(24)-336(\(66.7\))-4839.7(12)-330.2(\(33.3\))-4690(0.037)-2581.4(2.4)-333.6(\(1.1)-502.6(5.1\))]TJ -1.5548 -1.0135 TD [(Wound)-335.3(contamination)]TJ 1.002 -1.0135 TD [(No)-8053.2(2,437)-335.6(\(74.4\))-2783.9(2,123)-335.6(\(87.1\))-4338.7(314)-331.2(\(12.9\))-9521.4(1.0)]TJ 0 -1.0077 TD [(Yes)-8469.9(839)-337(\(25.6\))-3532.6(678)-337(\(80.8\))-4338.7(161)-331.2(\(19.2\))-4690(0.155)-2581.4(1.2)-333.6(\(0.9)-502.6(1.5\))]TJ -1.002 -1.0135 TD (Communication)Tj 1.002 -1.0135 TD [(Extra-oral)-5950.8(980)-337(\(29.9\))-3532.6(902)-337(\(92.0\))-4839.7(78)-330.2(\()-502(8.0\))]TJ /F7 1 Tf 34.7816 0 TD (<)Tj /F6 1 Tf .5528 0 TD [(0.001)-2581.4(1.0)]TJ -35.3344 -1.0135 TD [(Intra-oral)-5483.2(1,314)-335.6(\(40.1\))-2783.9(1,156)-335.6(\(88.0\))-4338.7(158)-331.2(\(12.0\))-4690(0.002)-2581.4(1.6)-333.6(\(1.1)-502.6(2.4\))]TJ 0 -1.0077 TD [(Communication)-3554.8(982)-337(\(30.0\))-3532.6(743)-337(\(75.7\))-4338.7(239)-331.2(\(24.3\))]TJ /F7 1 Tf 34.7816 0 TD (<)Tj /F6 1 Tf .5528 0 TD [(0.001)-2581.4(3.2)-333.6(\(2.3)-502.6(4.4\))]TJ -36.3364 -1.0135 TD [(Attending)-339.7(physician)-333.9(level)]TJ 1.002 -1.0135 TD [(Senior)-335.3(specialist)-2587.8(1,239)-335.6(\(37.8\))-2783.9(1,061)-335.6(\(85.6\))-4338.7(178)-331.2(\(14.4\))-4690(0.003)-2581.4(1.0)]TJ T* [(Junior)-334.2(specialist)-3451.6(517)-337(\(15.8\))-3532.6(424)-337(\(82.0\))-4839.7(93)-330.2(\(18.0\))]TJ /F7 1 Tf 34.7816 0 TD (<)Tj /F6 1 Tf .5528 0 TD [(0.001)-2581.4(1.7)-333.6(\(1.2)-502.6(2.2\))]TJ -35.3344 -1.0077 TD [(Non-specialist)-3485.2(1,520)-335.6(\(46.4\))-2783.9(1,316)-335.6(\(86.6\))-4338.7(204)-331.2(\(13.4\))-4690(0.460)-2581.4(1.1)-333.6(\(0.9)-502.6(1.4\))]TJ -1.002 -1.0135 TD (Sites)Tj 1.002 -1.0135 TD [(Tongue)-7459.8(63)-336(\()-496.2(1.9\))-4037.3(60)-336(\(95.2\))-5335(3)-335(\()-502(4.8\))]TJ /F7 1 Tf 34.7816 0 TD (<)Tj /F6 1 Tf .5528 0 TD [(0.001)-2581.4(1.0)]TJ -35.3344 -1.0077 TD [(Gum)-8020.9(173)-337(\()-496.2(5.3\))-3536.3(164)-337(\(94.8\))-5335(9)-335(\()-502(5.2\))-4688(0.581)-2581.4(1.5)-333.6(\(0.4)-502.6(5.7\))]TJ 0 -1.0135 TD [(Mandible)-6679.8(33)-336(\()-496.2(1.0\))-4037.3(31)-336(\(93.9\))-5335(2)-335(\()-502(6.1\))-4688(0.775)-2581.4(1.3)-333.6(\(0.2)-502.6(8.9\))]TJ T* [(Chin)-8072.8(323)-337(\()-496.2(9.9\))-3536.3(294)-337(\(91.0\))-4839.7(29)-330.2(\()-502(9.0\))-4688(0.105)-2581.4(2.9)-333.6(\(0.810.2\))]TJ T* [(Cheek)-7459.8(121)-337(\()-496.2(3.7\))-4037.3(95)-336(\(78.5\))-4839.7(26)-330.2(\(21.5\))-4690(0.017)-2581.4(4.7)-333.6(\(2.317.1\))]TJ 0 -1.0077 TD [(Lip)-7876.2(2,399)-335.6(\(73.2\))-2783.9(2,001)-335.6(\(83.4\))-4338.7(398)-331.2(\(16.6\))-4690(0.033)-2581.4(3.7)-333.6(\(1.112.0\))]TJ 0 -1.0135 TD [(Others)-7355.8(164)-337(\()-496.2(5.0\))-3536.3(156)-337(\(95.1\))-5335(8)-335(\()-502(4.9\))-4688(0.911)-2581.4(1.1)-333.6(\(0.3)-502.6(4.4\))]TJ 8.7511 0 0 8.7511 67.748 321.5054 Tm (OR)Tj /F7 1 Tf 1.5483 0 TD (=)Tj /F6 1 Tf .7191 0 TD [(odds)-337.1(ratio;)-332.3(CI)]TJ /F7 1 Tf 5.8435 0 TD (=)Tj /F6 1 Tf .7191 0 TD [(condence)-330.9(interval;)-335.2(ASA)]TJ /F7 1 Tf 10.5079 0 TD (=)Tj /F6 1 Tf .7191 0 TD [(American)-334.7(Society)-334.9(of)-333.1(Anesthesiologists.)]TJ /F4 1 Tf 8.9663 0 0 8.9663 59.7543 749.7069 Tm [(RISK)-335.9(FOR)-334(INFECTION)-337.6(OF)-337.5(MAXILLOFACIAL)-334.4(STIS)-29653.1(301)]TJ ET endstream endobj 46 0 obj <>stream /GS1 gs BT /F6 1 Tf 9.843 0 0 9.843 62.022 725.1588 Tm 0 0 0 rg 0 Tc 0 Tw [(a)-428.5(transoral)-432.7(route)-427.2(was)-425.6(correlated)-436.3(with)-426(a)-428.5(substantial)-429.3(risk)-430.5(of)]TJ 0 -1.1174 TD [(post-operative)-341.6(infection,)-338.6(further)-337.2(elucidating)-338.7(the)-332.9(role)-339.7(of)-330.5(oral)]TJ 0 -1.1116 TD [(contamination)-468.8(in)-463.1(post-operative)-474.1(infection)-461.9([24].)-468.5(Therefore,)]TJ T* [(peri-operative)-319.9(oral)-316.7(care)-318.9(is)-318.9(considered)-319.7(important)-317.9(in)-313.4(reducing)]TJ T* [(the)-281.1(infection)-283.3(rate)-283.3([22].)]TJ 1.0137 -1.1174 TD [(In)-474.5(addition,)-480.3(this)-482.5(study)-477.7(found)-477.8(that)-478.1(the)-476.9(infection)-484.9(rate)-479.1(of)]TJ -1.0137 -1.1116 TD [(communicating)-268.3(wounds)-266.5(that)-270.8(penetrated)-269.3(extra-orally)-270.4(to)-267.3(intra-)]TJ T* [(orally)-549.4(was)-552.3(higher)-549.3(than)-547.1(that)-553(of)-543.6(intra-)-8(oral)-547.1(wounds.)-546.4(Com-)]TJ 0 -1.1174 TD [(municating)-372.1(wounds)-375.9(are)-374.2(relatively)-372.1(heavy)-376.5(and)-367.3(deep,)-373(and)-373.1(the)]TJ 0 -1.1116 TD [(pollutants)-381.1(are)-380(more)-375.4(difcult)-384.6(to)-376.7(clean.)-381.2(Under)-376.1(the)-379(combined)]TJ T* [(action)-274.1(of)-272.9(bacteria)-278.6(gathering)-271.7(under)-271.6(the)-275.3(blood)-270.6(scab)-277.2(of)-272.9(the)-269.5(skin)]TJ 0 -1.1174 TD [(wound)-507.5(and)-499.8(the)-505.7(bacterial)-510.3(intra-oral)-503.2(environment,)-508.9(commu-)]TJ 0 -1.1116 TD [(nicating)-483.8(wounds)-485.3(are)-489.4(more)-479.1(likely)-486.2(to)-486.1(cause)-486.9(infection)-484.9([25].)]TJ T* [(Therefore,)-231(it)-227.1(is)-221(recommended)-232.3(that)-224.7(nursing)-226.5(measures)-232(be)-228(taken)]TJ T* [(to)-405.5(reduce)-413.2(the)-402(infection)-410(rate)-410(of)-405.3(communicating)-412.3(wounds.)-408.1(In)]TJ 0 -1.1174 TD [(addition)-286.8(to)-284.6(peri-operative)-291.1(oral)-282.1(care,)-287.8(topical)-286.9(antibiotic)-290.5(agents)]TJ 0 -1.1116 TD [(should)-369.4(be)-372(applied)-373.2(to)-365.2(the)-373.2(skin,)-370.6(the)-367.5(primary)-373(healing)-373.2(wounds)]TJ T* [(should)-236.9(be)-233.7(cleansed)-243.8(of)-232.6(scab)-236.9(tissue)-238(and)-240.6(residues)-235.5(of)-238.3(the)-235(surgical)]TJ 0 -1.1174 TD [(disinfectant)-362.6(after)-365(24)-359.3(hours,)-360.1(a)-359.4(protective)-360.4(dressing)-366.8(should)-357.9(be)]TJ 0 -1.1116 TD [(applied,)-405.4(and)-401.9(a)-399.7(moist)-404.2(wound)-398(environment)-407.6(should)-398.2(be)-406.5(main-)]TJ T* [(tained;)-367.5(these)-364.9(strategies)-365.8(have)-369.6(been)-363.8(shown)-363.3(to)-365.2(be)-366.2(effective)-366.1(in)]TJ 0 -1.1174 TD [(preventing)-347.6(wound)-346.2(infection)-346.7(involving)-344.4(skin)-344.2([23,26].)-341.7(The)-345.5(lip)]TJ 0 -1.1116 TD [(and)-436.4(cheek)-435.2(regions)-429.2(with)-437.5(thin,)-428.6(soft)-436.3(tissue)-433.9(that)-432(is)-434.1(more)-433(eas-)]TJ T* [(ily)-418.3(penetrated)-424.8(had)-419.2(a)-417(higher)-416.8(infection)-421.5(rate)-421.5(than)-420.4(other)-415.7(parts)]TJ 0 -1.1174 TD [(in)-491.9(this)-494(study.)-492.7(This)-495.1(was)-494.7(basically)-491.7(consistent)-497.2(with)-495.1(another)]TJ 0 -1.1116 TD [(study)-281.9([27].)]TJ 1.0137 -1.1116 TD [(At)-527.3(our)-527.4(institution,)-528.8(the)-523(pre-triage)-533(nurse)-530.6(determines)-528.4(the)]TJ -1.0137 -1.1116 TD [(receiving)-434.1(physician)-432.8(according)-434(to)-428.5(the)-430.8(maxillofacial)-435.5(STI.)-434(If)]TJ 0 -1.1174 TD [(the)-494.2(injury)-496.4(was)-500.5(serious,)-495.8(a)-491.8(professional)-499.2(surgeon)-498.2(\(junior)-497.5(or)]TJ 0 -1.1116 TD [(senior\))-348.6(performed)-353.2(the)-344.4(examination)-351.3(and)-350(suturing.)-346.3(The)-345.5(study)]TJ T* [(found)-345.3(that)-351.4(the)-344.4(infection)-352.4(rate)-352.4(of)-342(STIs)-350.8(sutured)-348.6(by)-347.8(senior)-347.5(sur-)]TJ 0 -1.1174 TD [(geons)-271.4(was)-275.8(lower)-272.6(than)-276.4(that)-270.8(of)-272.9(junior)-271.8(surgeons.)-277.9(The)-270.6(impact)-275.4(of)]TJ 0 -1.1116 TD [(physician)-409.7(experience)-408.6(and)-407.6(technology)-405.3(on)-405.4(infection)-404.3(was)-408.3(the)]TJ T* [(same)-186.3(as)-181.7(that)-178.6(reported)-184(in)-180.9(other)-179.6(studies)-187.3([28,29].)-180.4(Good)-178.1(technique)]TJ 0 -1.1174 TD [(during)-467.5(surgery)-469.4(for)-469.8(incision)-470.9(or)-462.9(laceration)-476.8(closure)-470.7(is)-468.7(much)]TJ 0 -1.1116 TD [(more)-392.7(important)-398.6(than)-391.6(any)-396.1(manipulation)-397.4(of)-393.8(the)-390.5(wound)-398([28].)]TJ T* [(The)-190(infection)-196.9(rate)-191.1(was)-189.5(related)-195.7(to)-186.6(the)-194.7(personnel)-190.7(performing)-192(the)]TJ T* [(repair,)-576.9(suggesting)-576.5(differences)-575.3(in)-572.5(wound)-576.6(preparation)-574.5(and)]TJ 0 -1.1174 TD [(repair)-337.3(techniques)-337.1(between)-334.7(emergency)-338.3(departments)-339.4(and)-332.8(sur-)]TJ 0 -1.1116 TD [(gical)-457.4(personnel)-461.4([29].)-457(In)-457.2(addition)-459.6(to)-457.3(differences)-465.9(in)-451.6(wound)]TJ T* [(treatment)-343.3(and)-338.5(suture)-341.7(skills,)-338.3(senior)-341.7(surgeons)-343.6(are)-339.7(more)-335.1(expe-)]TJ 0 -1.1174 TD [(rienced)-299.3(in)-301.8(post-operative)-301.3(wound)-300.1(management,)-298.2(such)-299.1(as)-302.7(local)]TJ 0 -1.1116 TD [(use)-303.8(of)-301.7(antibiotic)-302(agents/ointment,)-307.4(wound)-300.1(drainage,)-303.8(and)-298.2(tim-)]TJ T* [(ing)-493(and)-488.3(number)-492.8(of)-491.7(patient)-494.2(follow-up)-494.8(visits.)-488.1(Whet)-8(her)-488.2(the)]TJ 0 -1.1174 TD [(above)-370.7(factors)-378.5(affect)-373(the)-367.5(wound)-375(infection)-369.7(rate)-375.4(has)-372.9(not)-366.3(been)]TJ 0 -1.1116 TD [(further)-366(studied,)-369.5(which)-370.5(is)-365(a)-365.1(limitation)-371.3(of)-365(this)-367.3(study.)-366(Further)]TJ T* [(research)-191.8(is)-192.2(planned)-188.7(to)-192.4(more)-185.3(thorou)-6.7(ghly)-188.8(examine)-191.1(discuss)-187(more)]TJ 0 -1.1174 TD [(detailed)-260.4(factors)-257.6(in)-255.8(further)-256.6(research)-260.9(to)-255.8(that)-259.3(may)-259.1(guide)-254.5(clinical)]TJ 0 -1.1116 TD (treatment.)Tj /F4 1 Tf 8.9663 0 0 8.9663 62.022 170.8157 Tm (Conclusions)Tj /F6 1 Tf 9.843 0 0 9.843 72 154.3747 Tm [(This)-282(study)-281.9(analyzed)-290.1(the)-281.1(infection)-283.3(rate)-289(after)-284.4(suturing)-279.6(max-)]TJ -1.0137 -1.1116 TD [(illofacial)-550.8(penetrating)-551.6(STIs.)-550.1(Increased)-550(age,)-550.5(longer)-549.3(wound)]TJ T* [(length)-365.1(\()]TJ /F7 1 Tf 3.2082 0 TD (>)Tj /F6 1 Tf .5529 0 TD [(4)-162.4(cm\),)-366.2(intra-oral)-365(and)-367.3(communicating)-366.3(wounds,)-362.1(and)]TJ -3.7611 -1.1174 TD [(lip)-291.5(or)-290.2(cheek)-297(sites)-294.5(increased)-296.7(the)-292.6(infection)-294.8(rate.)-292.5(No)-291.1(difference)]TJ 0 -1.1116 TD [(was)-489(found)-483.5(regarding)-484.6(gender,)-490.4(physical)-483.5(condition,)-487.2(diabetes)]TJ T* [(mellitus,)-470(wound)-461.4(age)-466.4(or)-468.7(contamination.)-466.5(Even)-467.5(if)-463.1(the)-465.4(pene-)]TJ 0 -1.1174 TD [(trating)-481.5(wound)-484.4(age)-477.9(exceeds)-484.5(24)-480.3(hours,)-481(it)-480.5(is)-485.9(meaningful)-481.3(to)]TJ 0 -1.1116 TD [(suture)-393.6(if)-388.2(there)-393.8(is)-388(no)-388.1(serious)-394.5(infection.)-390.4(For)-389(wounds)-393.2(at)-389.4(high)]TJ T* [(risk)-367.2(of)-370.8(infection,)-367.4(further)-371.8(measures)-370.2(should)-369.4(be)-366.2(considered)-371.5(to)]TJ 25.504 66.8932 TD [(reduce)-430.5(the)-425.1(possibility)-427.1(of)-422.6(infection,)-425(improving)-426.1(the)-425(surgical)]TJ 0 -1.1174 TD [(training)-551.7(of)-543.6(junior)-548.2(surgeons,)-548.6(and)-545.9(improving)-547(the)-546(patients)]TJ 0 -1.1116 TD [(wound)-282.8(care.)]TJ /F4 1 Tf 8.9663 0 0 8.9663 313.0582 673.3416 Tm [(Funding)-340.9(Information)]TJ /F6 1 Tf 9.843 0 0 9.843 323.0361 656.9006 Tm [(This)-495.1(research)-491.3(was)-494.7(supported)-494.8(by)-486(the)-494.2(Program)-493.7(for)-492.8(New)]TJ -1.0137 -1.1116 TD [(Clinical)-542.6(Techniques)-545.5(and)-540.1(Therapies)-538.6(of)-537.8(Peking)-543.4(University)]TJ 0 -1.1174 TD [(School)-284.2(and)-280.9(Hospital)-281.8(of)-284.4(Stomatology)-279.7(\(PKUSSNCT-18B06\).)]TJ /F4 1 Tf 8.9663 0 0 8.9663 313.0582 605.0833 Tm [(Author)-338.7(Disclosure)-336.7(Statement)]TJ /F6 1 Tf 9.843 0 0 9.843 323.0361 588.6423 Tm [(No)-279.5(conicting)-284.3(nancial)-283.1(interests)-288.7(exist.)]TJ /F4 1 Tf 8.9663 0 0 8.9663 313.0582 563.7542 Tm (References)Tj /F6 1 Tf 9.2951 0 0 9.2951 317.707 547.7101 Tm [(1.)-500.4(Guo)-581.4(HQ,)-582.9(Yang)-585.8(X,)-581.2(Wang)-582.5(XT,)-577.2(et)-583.3(al.)-583.4(Epidemiology)-579(of)]TJ 1.2503 -1.1284 TD [(maxillofacial)-603.3(soft)-599.2(tissue)-593.8(injuries)-602.8(in)-597.4(an)-596.1(oral)-598.2(emergency)]TJ 0 -1.1223 TD [(department)-600.3(in)-591.3(Beijing:)-593.4(A)-587.2(two-year)-594.6(retrospective)-600.2(study.)]TJ 0 -1.1284 TD [(Dent)-335.1(Ttaumatol)-338.8(2021;37:479487.)]TJ -1.2503 -1.1223 TD [(2.)-500.4(Hollander)-354(JE,)-349(Singer)-351.3(AJ,)-348.7(Valentine)-355.3(S,)-344.7(Henry)-350.4(MC.)-352.1(Wound)]TJ 1.2503 -1.1284 TD [(registry:)-550.4(Development)-551(and)-547.5(validation.)-550.5(Ann)-544.8(Emerg)-545.4(Med)]TJ T* (1995;25:675685.)Tj -1.2503 -1.1223 TD [(3.)-500.4(Quinn)-386(JV,)-385.3(Polevoi)-391.2(SK,)-383(Kohn)-386.4(MA.)-385.5(Traumatic)-388.6(lacerations:)]TJ 1.2503 -1.1284 TD [(what)-201(are)-194.1(the)-199.2(risks)-195.9(for)-194.1(infection)-193.3(and)-199.8(has)-192.8(the)-199.2(golden)-196(period)-192.3(of)]TJ 0 -1.1223 TD [(laceration)-238.4(care)-229(disappeared?)-237.1(Emerg)-234.4(Med)-229.6(J)-231(2014;31:96100.)]TJ -1.2503 -1.1284 TD [(4.)-500.4(Tabaka)-344.7(ME,)-337(Quinn)-337.2(JV,)-336.5(Kohn)-337.6(MA,)-336.7(Polevoi)-336.3(SK.)-340.3(Predictors)]TJ 1.2503 -1.1223 TD [(of)-466.1(infection)-461.7(from)-462.2(dog)-464(bite)-461.1(wounds:)-464.7(Which)-460.1(patients)-464.4(may)]TJ 0 -1.1284 TD [(benet)-359.3(from)-352.4(prophylactic)-350.4(antibiotics?)-358.3(Emerg)-356.4(Med)-351.6(J)-353(2015;)]TJ 0 -1.1223 TD (32:860863.)Tj -1.2503 -1.1284 TD [(5.)-500.4(Chhabra)-583.8(S,)-582.5(Chhabra)-583.8(N,)-581.2(Gaba)-583.9(S.)-582.5(Maxillofacial)-584.6(injuries)]TJ 1.2503 -1.1223 TD [(due)-358.4(to)-353.5(animal)-361.5(bites.)-356.7(J)-353(Maxillofac)-355.5(Oral)-361.9(Surg)-353.4(2015;14:142)]TJ 0 -1.1284 TD (153.)Tj -1.2503 -1.1223 TD [(6.)-500.4(Singer)-387.9(AJ,)-385.3(Quinn)-386(JV,)-379.2(Thode)-385(HC,)-384.9(Hollander)-390.6(JE.)-385.6(Determi-)]TJ 1.2503 -1.1284 TD [(nants)-271.8(of)-264.9(poor)-265.2(outcome)-264.6(after)-269.4(laceration)-268.9(and)-266.9(surgical)-266(incision)]TJ 0 -1.1223 TD [(repair.)-336.7(Plast)-335.1(Reconstruct)-336.5(Surg)-335.2(2002;110:429435.)]TJ -1.2503 -1.1284 TD [(7.)-500.4(Hollander)-622.4(JE,)-617.4(Singer)-613.5(AJ,)-617.1(Valentine)-617.6(S.)-619.1(Comparison)-614.7(of)]TJ 1.2503 -1.1223 TD [(wound)-557.3(care)-558.3(practices)-561.3(in)-554.7(pediatric)-563.5(and)-553.6(adult)-558.8(lacerations)]TJ 0 -1.1284 TD [(repaired)-304.5(in)-298.6(the)-296.8(emergency)-300.6(department.)-301.6(Pediatr)-300.2(Emerg)-295.4(Care)]TJ 0 -1.1223 TD (1998;14:1518.)Tj -1.2503 -1.1284 TD [(8.)-500.4(Hollander)-415(JE,)-416.1(Singer)-412.3(AJ,)-415.8(Valentine)-416.3(SM,)-411.2(Shofer)-415.2(FS.)-408.7(Risk)]TJ 1.2503 -1.1223 TD [(factors)-348.1(for)-346.6(infection)-345.8(in)-347.4(patients)-348.5(with)-342.6(traumatic)-349.6(lacerations.)]TJ 0 -1.1284 TD [(Acad)-339.9(Emerg)-332(Med)-333.3(2001;8:716720.)]TJ -1.2503 -1.1223 TD [(9.)-500.4(Ottinger)-544.3(ME,)-544.3(Monaghan)-545.6(SF,)-536.8(Gravenstein)-546.7(S,)-539.8(et)-546.7(al.)-540.7(The)]TJ 1.2503 -1.1284 TD [(geriatric)-388.9(cytokine)-386.6(response)-382.2(to)-384(trauma:)-382.2(Time)-383.8(to)-384(consider)-388.6(a)]TJ 0 -1.1223 TD [(new)-335.6(threshold.)-335.2(Surg)-335.1(Infect)-336.6(2014;15:800805.)]TJ -1.7505 -1.1284 TD [(10.)-500.5(Singh)-521.5(S,)-521.5(Young)-520.7(A,)-520.2(McNaught)-522.2(C-E.)-521.8(The)-525(physiology)-517.9(of)]TJ 1.7505 -1.1223 TD [(wound)-337.8(healing.)-331.6(Surgery)-336(2017;35:473477.)]TJ -1.7505 -1.1284 TD [(11.)-500.5(Kuwabara)-360.8(K,)-361.6(Imanaka)-357.1(Y,)-355.6(Ishizaki)-357.5(T.)-362(Quality)-358.8(and)-352.3(produc-)]TJ 1.7505 -1.1223 TD [(tive)-387.9(efciency)-388.7(in)-384(simple)-386.9(laceration)-384.8(treatment.)-386.2(J)-383.5(Eval)-390.4(Clin)]TJ 0 -1.1284 TD [(Pract)-337(2006;12:164173.)]TJ -1.7505 -1.1223 TD [(12.)-500.5(Hansis)-608.1(M.)-603.3(Pathophysiology)-604.4(of)-606.4(infectionA)-604(theoretical)]TJ 1.7505 -1.1284 TD [(approach.)-339.4(Injury)-334.3(1996;27\(Suppl)-335.3(3\):Sc58.)]TJ -1.7505 -1.1223 TD [(13.)-500.5(Park)-540.6(D,)-538.5(Cha)-540.1(B,)-535.6(Myung)-536.7(Y.)-538.5(Characteristics)-547(of)-533.2(panfacial)]TJ 1.7505 -1.1284 TD [(fractures)-483(in)-475.4(the)-479.8(elderly:)-479.8(Etiology,)-477.1(fracture)-483.7(patterns,)-479.6(con-)]TJ T* [(comitant)-672.2(injuries,)-670(and)-669.5(postoperative)-672.9(complication)-670.4(risk.)]TJ 0 -1.1223 TD [(J)-334.7(Craniofac)-339.9(Surg)-335.2(2020;31:14211423.)]TJ -1.7505 -1.1284 TD [(14.)-500.5(Sta)11.3(mo)12.3(u)-262.4(SC,)-252(Mal)15(tez)16.1(ou)-256.5(HC)11.7(,)-262.3(Psa)11.7(lt)13.1(opo)17.9(ulo)12.3(u)-262.4(T)0(,)-252.2(e)0(t)-260.1(al.)-248(Wou)13.5(nd)-256.5(in)12.5(-)]TJ 1.7505 -1.1223 TD [(fec)13.2(tio)12.9(ns)-164.1(af)11.5(ter)-158.9(min)12.8(or)-161.2(lim)13.4(b)-164.8(lace)17.9(rat)11.9(io)12.5(ns:)-157.6(Ris)14.5(k)-170.9(f)0(a)11.5(cto)14.2(rs)-166.4(an)13.8(d)-170.9(t)0(h)12.5(e)-169(role)]TJ 0 -1.1284 TD [(of)-240.5(ant)14.2(imi)13.3(cr)11.5(obi)12.3(al)-235.7(agen)15.4(ts)13.4(.)-244(J)-249.3(Tr)13.8(aum)14.1(a)-248.3(199)17.9(9;)12.5(46:)12.3(107)17.9(81)17.9(081)17.9(.)]TJ -1.7505 -1.1223 TD [(15.)-500.5(Rehman)-416.2(L,)-404.7(Ghani)-414.6(E,)-410.8(Hussain)-407(A,)-410.4(et)-412.6(al.)-406.5(Infection)-415.8(in)-408.4(com-)]TJ 1.7505 -1.1284 TD [(pound)-275.2(depressed)-270.6(fracture)-276.3(of)-271(the)-272.4(skull.)-267.1(J)-273.7(Coll)-272.6(Phys)-271(Surg)-268.1(Pak)]TJ 0 -1.1223 TD (2007;17:140143.)Tj /F4 1 Tf 8.9663 0 0 8.9663 62.022 749.6502 Tm (302)Tj 48.8255 0 TD [(GUO)-331.4(ET)-338.7(AL.)]TJ ET endstream endobj 50 0 obj <>stream /GS1 gs BT /F6 1 Tf 9.2951 0 0 9.2951 59.7543 725.1588 Tm 0 0 0 rg 0 Tc 0 Tw [(16.)-500.5(Perelman)-335.1(VS,)-334.2(Francis)-336.4(GJ,)-330.4(Rutledge)-336.5(T,)-331.5(et)-333.3(al.)-333.4(Sterile)-336.2(versus)]TJ 1.7505 -1.1223 TD [(nonsterile)-290.1(gloves)-290.3(for)-285.6(repair)-287.8(of)-289.3(uncomplicated)-291(lacerations)-292.6(in)]TJ 0 -1.1284 TD [(the)-357.8(emergency)-361.6(department:)-355.9(A)-355.5(randomized)-363(controlled)-352(trial.)]TJ 0 -1.1223 TD [(Ann)-337.5(Emerg)-332(Med)-333.3(2004;43:362370.)]TJ -1.7505 -1.1283 TD [(17.)-500.5(Pavan)-268.2(F,)-259.3(Albarki)-264.1(HS,)-267.1(Vu)-264.1(J,)-261.6(et)-266.2(al.)-260.2(Does)-267.7(delay)-264.7(to)-262(theater)-264.9(lead)]TJ 1.7505 -1.1223 TD [(to)-262(increased)-256.9(infection)-260.4(rates)-260.1(in)-262(hand)-254.9(trauma?)-258.9(A)-257.9(retrospective)]TJ 0 -1.1284 TD [(cohort)-452.1(study.)-450.7(Plast)-451(Reconstruct)-452.3(Surg)-451(Glob)-446.8(Open)-451.6(2018;6:)]TJ 0 -1.1223 TD (e2025.)Tj -1.7505 -1.1284 TD [(18.)-500.5(va)19.9(n)-225.8(d)0(e)19.9(n)-225.8(Ba)21.2(ar)-220.3(M)12.8(T)0(,)-215.6(v)0(a)19.9(n)-225.8(de)19.9(r)-222(P)0(a)17(l)0(e)20.5(n)-225.8(J,)-212.8(Vr)14.1(oo)24.1(n)-225.8(M)0(I)16.4(,)-219.6(et)-217.4(al)20.5(.)-225.7(I)0(s)-215.2(t)12.6(im)19(e)-223.9(t)0(o)]TJ 1.7505 -1.1223 TD [(cl)14.4(os)25(ur)15.7(e)-364.2(a)-370.3(fa)23.7(ct)14.4(or)-356.4(i)12.6(n)-366.1(t)12.6(h)0(e)-358.2(o)0(c)19.9(c)0(u)19.9(r)0(r)19.5(e)0(n)13.8(c)14(e)-370.3(o)0(f)-356.4(i)12.6(nf)21.8(ec)15.7(ti)19.2(on)-354(in)-359.6(t)12.6(r)0(a)17.6(u)0(m)18.4(a)14(ti)19.2(c)]TJ 0 -1.1284 TD [(wo)16.4(un)18(ds)25(?)-510.6(A)-507.9(pr)21.8(os)18.9(pe)19.9(ct)20.5(iv)18.6(e)-504.5(c)0(o)13.8(h)0(o)24.1(r)0(t)-496.1(s)0(t)19.5(u)0(d)18(y)-506.4(i)12.6(n)-506.4(a)-510.6(D)0(u)22.5(t)0(c)14.4(h)-500.3(le)14.4(ve)19.9(l)-505.8(1)]TJ 0 -1.1223 TD [(tr)16.3(au)19.9(m)12.5(a)-327.6(ce)21.8(nt)18.6(re)17.6(.)-323.3(E)0(m)16.6(e)14(rg)-313.7(Me)14.5(d)-323.4(J)-322.5(20)18(10)24.1(;2)18.6(7:)18.6(54)18(0)24.1(54)18(3.)]TJ -1.7505 -1.1284 TD [(19.)-500.5(Zehtabchi)-319.6(S,)-320.3(Tan)-317.6(A,)-312.9(Yadav)-321.8(K,)-312.9(et)-321.1(al.)-315.1(The)-317.6(impact)-318.8(of)-313.7(wound)]TJ 1.7505 -1.1284 TD [(age)-374.8(on)-366.2(the)-376.1(infection)-370.2(rate)-370.6(of)-368.6(simple)-374.7(lacerations)-378(repaired)-371.6(in)]TJ 0 -1.1223 TD [(the)-333.4(emergency)-337.2(department.)-338.2(Injury)-334.3(2012;43:17931798.)]TJ -1.7505 -1.1284 TD [(20.)-500.5(Keim)-395.7(A,)-398.2(Marinucci)-398.6(J.)-389.7(Making)-394.1(better)-400.8(wound)-392.7(management)]TJ 1.7505 -1.1223 TD [(decisions.)-336.2(JAAPA)-336.8(2019;32:1522.)]TJ -1.7505 -1.1284 TD [(21.)-500.5(Dubay)-317.6(DA,)-314.6(Franz)-313.2(MG.)-318.4(Acute)-315.1(wound)-313.4(healing:)-312.8(The)-317.6(biology)]TJ 1.7505 -1.1223 TD [(of)-301.5(acute)-305.5(wound)-301.2(failure.)-305.8(Surg)-304.7(Clin)-303.1(North)-302.9(Am)-300.3(2003;83:463)]TJ 0 -1.1284 TD (481.)Tj -1.7505 -1.1223 TD [(22.)-500.5(Kamizono)-376.1(K,)-373.8(Sakuraba)-372.8(M,)-371.5(Nagamatsu)-379.6(S,)-369.1(et)-376(al.)-369.9(Statistical)]TJ 1.7505 -1.1284 TD [(analysis)-592.2(of)-582(surgical)-589.3(site)-588.3(infection)-589.7(after)-586.5(head)-588.4(and)-584.1(neck)]TJ 0 -1.1223 TD [(reconstructive)-594.2(surgery.)-582.4(Ann)-587.5(Surg)-585.2(Oncol)-585.4(2014;21:1700)]TJ 0 -1.1284 TD (1705.)Tj -1.7505 -1.1223 TD [(23.)-500.5(Heal)-241.8(CF,)-233.7(Banks)-240.6(JL,)-233.1(Lepper)-239.2(PD,)-236.6(et)-241.8(al.)-235.8(Topical)-235.8(antibiotics)-244.1(for)]TJ 1.7505 -1.1284 TD [(preventing)-529.5(surgical)-534.4(site)-527.3(infection)-528.7(in)-530.3(wounds)-526.1(healing)-532.8(by)]TJ 0 -1.1223 TD [(primary)-429.7(intention.)-430.2(Cochrane)-429.5(Database)-432.9(Syst)-422.9(Rev)-430.3(2016;11:)]TJ 0 -1.1284 TD (Cd011426.)Tj 25.263 30.3864 TD [(24.)-500.5(Fialkov)-299.7(JA,)-306(Holy)-300.4(C,)-303.9(Forrest)-304.1(CR,)-302.7(et)-302.8(al.)-302.9(Postoperative)-303.8(infec-)]TJ 1.7505 -1.1223 TD [(tions)-303.7(in)-304.7(craniofacial)-306.3(reconstructive)-307.6(procedures.)-304.6(J)-304.2(Craniofac)]TJ 0 -1.1284 TD [(Surg)-329.1(2001;12:362368.)]TJ -1.7505 -1.1223 TD [(25.)-500.5(Field)-384.8(FK,)-383(Kerstein)-389.6(MD.)-385.5(Overview)-386.5(of)-380.8(wound)-386.6(healing)-386.4(in)-384(a)]TJ 1.7505 -1.1283 TD [(moist)-333.7(environment.)-334.1(Am)-336.9(J)-334.7(Surg)-329.1(1994;167:2s6s.)]TJ -1.7505 -1.1223 TD [(26.)-500.5(Kujath)-615.4(P,)-606.9(Michelsen)-621.1(A.)-611.7(Wounds:)-613.8(From)-615.3(physiology)-609.4(to)]TJ 1.7505 -1.1284 TD [(wound)-331.7(dressing.)-334.8(Dtsch)-334.4(Arztebl)-341.5(Int)-331.5(2008;105:239248.)]TJ -1.7505 -1.1223 TD [(27.)-500.5(Wang)-472.7(LH,)-473.5(Yang)-476(Z,)-471.7(Yang)-476(H,)-471.4(et)-473.6(al.)-473.6([Analysis)-476.1(of)-472.2(factors)]TJ 1.7505 -1.1284 TD [(affecting)-413.9(soft)-410.1(tissue)-416.9(infection)-412.9(after)-415.7(oral)-409.1(and)-413.3(maxillofacial)]TJ 0 -1.1223 TD [(debridement].)-377.4(Shanghai)-377.9(Kou)-374.1(Qiang)-371.9(Yi)-379.4(Xue)-372.2(2017;26:461)]TJ 0 -1.1284 TD (464.)Tj -1.7505 -1.1223 TD [(28.)-500.5(Goldberg)-338.1(HM,)-336.7(Rosenthal)-341.8(SA,)-340.3(Nemetz)-343.4(JC.)-339.7(Effect)-338.5(of)-338.1(wash-)]TJ 1.7505 -1.1284 TD [(ing)-402.4(closed)-410.4(head)-411.5(and)-407.2(neck)-405.4(wounds)-410.2(on)-408.9(wound)-404.9(healing)-410.8(and)]TJ T* [(infection.)-333.6(Am)-336.9(J)-328.6(Surg)-335.1(1981;141:358359.)]TJ -1.7505 -1.1223 TD [(29.)-500.5(Drumright)-310.9(B,)-316.1(Borg)-312.6(B,)-316.1(Rozzelle)-314.4(A,)-319(et)-308.9(al.)-315.1(Pediatric)-316.3(dog)-317.6(bite)]TJ 1.7505 -1.1284 TD [(outcomes:)-403.7(Infections)-408.9(and)-407.2(scars.)-412.3(Trauma)-409.5(Surg)-402.2(Acute)-406.6(Care)]TJ 0 -1.1223 TD [(Open)-335.7(2020;5:e000445.)]TJ 9.843 0 0 9.843 438.803 531.4959 Tm [(Address)-331.9(correspondence)-343.5(to:)]TJ /F12 1 Tf 6.6985 -1.1116 TD [(Dr.)-334.6(Jie)-334.1(Bai)]TJ -8.3689 -1.1116 TD [(Department)-337.7(of)-336.4(Oral)-333.5(Emergency)]TJ -9.4805 -1.1116 TD [(Peking)-338.6(University)-337.9(School)-336.2(and)-331.6(Hospital)-338.2(of)-330.6(Stomatology)]TJ -.0634 -1.1174 TD [(No.)-335(22,)-333.9(Zhongguancun)-336.8(South)-333.9(Avenue,)-337.3(Haidian)-331.4(District)]TJ 16.2654 -1.1116 TD [(Beijing)-333(100081)]TJ 1.7279 -1.1116 TD [(P.R.)-334(China)]TJ -7.5222 -2.1253 TD (E-mail:)Tj /F6 1 Tf 3.3982 0 TD (jiebai1999@163.com)Tj /F4 1 Tf 8.9663 0 0 8.9663 59.7543 749.7069 Tm [(RISK)-335.9(FOR)-334(INFECTION)-337.6(OF)-337.5(MAXILLOFACIAL)-334.4(STIS)-29653.1(303)]TJ ET endstream endobj 54 0 obj <>stream 8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0 b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup` E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn 6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O( l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~> endstream endobj 56 0 obj <>stream h,nAYK94<U!(RU J* q{^p" Ӥ: kbX#O:9uppmc0{v߻퓗;dygvz}q``6`|tݏ D9gCdJ8d)[r!эLYE^i#4OLUyT6C>cb46lHjGȤ2h!jM[ȹlűFQ`ds7vR'Qu Ò^ x3 ##?܊d}XK%{*IqM<ԡD I(]a | ؈"z:IR~C9NlW8c2̉fQ$yfTir UJYIqшMsI Q, *R|~vZ ^u$XDTa9X (A1!  endstream endobj 58 0 obj <>stream hlWyTLb`[ŒĊnUTE"ְd$BBXdIeDwQۺmh{[o֥z[~O^zoh=9Ǽ3y~:p9nݱ'.@RNY?I32N9rCѽH _.W8GnMȖ$%$c×Vy_}wJO\zP?[*J;b%h0n@# 1@T(b$ Z D S%)xRZ,;C(.N[.$I3cIqIђ$tq`/t8r^vq8ם8K9+98os88-.NPg5K lja:%8w<3?{FScp^_.6fy-33ͼK|gY^fpv_¿ٞ_ga?/-|Fe{v;)-[oJ6K$QkFd۰qe*_G"7ƁzjŎ6TvG\/F^;Δ+y٤]Mm![z; N{~̹\;څVlB+7gD @/,gpoG[ 3ik?кX@VY1OG }y|!t~v}KFȱd2@"w:~$P:  * mT$Eؗa$cg`CTu- )Gݠ{<*:.gs!BiY7!% nV;hia݆,&-EL6^1aUnj)Zڐ z*?7"ְȃoHP2vR(Ђ8l6vtG+BnS{v'!Z x$ÔsAcJoCUp'ykK ɥJޕq WAn VG?$}'qzw.[~u--DmJEm]MAk~ /݉[C7l~o1Ccw;oU0of"WVĎGGۇ(4]" +gg`!`?'.CPGGWE_zW}֡q[H"mma~gӽꑴR%?z}~FU}~]);H15*qZɖں `iBa&Q]BƊ JS`%` `&E5lAΒ:oV$p-Q ?m2ēJ]fFS90lh>S%m*^h!rqF4?-b\{LNR3[ӵ0, /nP6Ebk뛟Ge>(|~Â*DXy}.kE?' NZ 솵Hɠnuee+!WdtjGzY1*Rd6Pov3%DA8]SpT ʠMې]VQh" Z[<jrS 2l7~{QEF>0$:i>ch3~ lo۸i`p!|.bm K3Lgx|)+ H=QKS9k =,ь*S4c{t*|Lþ!צ%צHDI X>RZUNeT2Q۹ 7jM+=%2/qPW^S0bZ Ug ͪx<=iy*qL1aPN} Vbjk^.uo `#rDv@i dppF:~Inw%/EP$r3‚VUxr;;΄ 6e~7kFZ P~wa)PɠRGԔۺ(pAø%7d>7lDI՟ۿaA'_3&Шɢqd&r+nmq4DVj Wt8a ul{gLDbH(y^y)ϖGP7xc%hM!VRKi%-7%! KvmYEcgď)YWx.1`U⇑W,`3>%SKQax w{X +O86F%(M.%¢29UlatC deحџ|faBHNi5LPO<\j!Z"M~Og ; f^T9hOcx/b4vWQ%덆dFmv , &ϣ455eu#4 ׫,J]ƨӗG?t,}4*U4~_)g*Is.3]"$ ;+N :kb=O4*DhQ K=dQt(&33}4 )$~v9:F汷!=6pga9Q+.ruՕ*'`Z8՘E%^;~˗m_P zKh#e ;YxluɬV:O"4}v  XV6UoԯLo7qcTU1C `V=;NP5UF djc.-EM/ISj Gȓׯ@O8 ?ځrEc#>] Xfb}AJN:~׾@^1E֏ݎσ:! ,LKd`#ExHx sq 9B/Tm쮱S2t1Z6S\1rSE)DYbٽY~kbe=t[ށ[:aezB+21~';7UW{hLz^Tj 4QWZĻoE^!: .au[HTl4ٙ~hV *b-ob ''/ ͵f  )PsO4ӘIF6evmڌ˼Sع'Ym/"VTU#j[I14=%r::YGl@΁{iQJ!+*=u%%.T?= sMER: Iqt$Mըs;S)R}P{Y'uNjFDErN%ٛT0V9? endstream endobj 59 0 obj <>stream 8;Z]"$PJ(7$q.X%n'h/Qb$:hb;*d_YK^`\uB6:4d??]+/$LgS1'1e>;$<+=..S3#e <\'$7`kGGD!&"FP=-mBG0sI366o,Ek]-Xcud5G@/#oAb18.ClCWP\e>Hp`$?b5H;H Eu'8?0Q8jL/tjf'5I+1VM:L>Y*S4$)5GE[(XCLf5-*FME,2>Pdf"%_De$ZE,hj0bi I0_SDZSaO*E3Alq#oJt:%a1fm,/[+"89c;XNRY5,?[HCDri4pCPAN=B0m.qJ=-.@t 7nedDA?9aMi]F-hH2btDl+8T=I^cuIaQLMN*3A-^=AQsgd;6bap7.(D?AsTG"pkQ! %*Zf%D*KhI`7OAM1>Pf$"fj,s%%c$%R_B\B+Ce9laeI+>fMATg>#\0":0AJE06ef9 Z,L17!O]YK9=1)c5N*<)"ouBI\Q&~> endstream endobj 24 0 obj <>stream 8;Z\7!=j`9#jhRUaENq%S(7Xb7A4>:8=$3nj6eJ@7/h0M>&2IA/%1*).DL'-_1ZJ] aSHf]`^:%%,5E'+kZ8%ka=jPjANP@oW8\f#d+[*(0EfH%:Bod`.^!m7Bg`KAoHk$)Za3D d9Y.r@&gO\\hU-70J2U]F0pI-fqUEOTt;VagAt?\?[*SH1XJCi/c%93Pt@4R`Z-Y- &a,U(j[lOkhQZ99;>@mZG_b..p4J7>HEDro`U-PCg-?%4W ![RX/C_%s>L\&.Vnh.&^)@aNTaLhB0]aqAi6J&L&f$3;^'s'YR8p=jNQJNn6gakg[ [qd"VjcuQ[pnAH/M=\UHDiEkaqJVh1>JFj37KeT]9TCt?+`PeIY]B]Z@q:N7cLmO( 2.@.0NDZc< endstream endobj 37 0 obj <>stream 8;Z]!CD+N-#_]bg"hdZD12R*r;.MOr-Ms_'L#6dHZ'8<7+rYgn&/o/p%VfbE7_Bn9 %SO]_s4@)6r5%:Pfj%8"Lj6%snFqSip)c'A0S1bjM=D=X=Q,XDY[!@=bDZ;2J0(C. AMV.LDG%Z6>SOU4GNsN?p3*PNY!kSJqXBCl`bi!t#Pl"ZE*Y8Wjb<%SUj@?pFE3KN ljRj?ms?%m\G#4b"m^SGbs;L%\2>Y*4YA9KB8_]JenVIpTD^g5!WZaAEPW#oHW<>m 4@2J9UkA3/J?k(NH!]WWW0P&j[#EhkpD+S->J%e%27VMH;q5Bj-Zo!T.q9VLVb8n^ @+/8JXIN5EnIO>TIdj&_\-sn/Krd/fUMeO!@GW4jl..?(@=>l?H2/M^@&[<0Y)+n+ EiD4#:H7?RKioM;Ch:/rI=T@>cdl_/ck$Wn~> endstream endobj 43 0 obj <>stream 8;Z\6!=jc*%.jK@gikApkFKMMD2a(6fYg0W8m;KjoH8^%gYUNes-p^dpRNE<$,pEq PBAlp4C(fc$*X7'j4glsl/b09T$TAL[UV-PCjA\&b+8@j.9jBtoq?BQfjk=(H`D'_ QqO"*-(nkBX9idL0<^Os]!uKjl["BXWb3tG(gOb";0>bL&1+U,T#:"c?Abo45(Ufs ;m".;6:/VUc5sU)3Kp=5RE#S7[-j("cITt*ok+f'!(I[I/+'V'*(!!59%O2HCGC=D ]F:s+GH'pt,Gtq6;+-JmeQH6]M!+m>EZ#.g(uL]WD?hhkX$Up(2!I>Q[!R+/c--RV ;>,]V:V9Q;>9PZJT$>Dajf3ee1bVK@[0UaBEC(N-d2^CD/To_f9T)V&@3'W'IfjLm ]ld-9,0Y$A7$[./kIOGqGqQbMlL=A_D"m_Z"#'9@i9#7n!;to(UA~> endstream endobj 47 0 obj <>stream 8;Z\7>EZlH%-.='oQ<4Da"H$8'9i,7r^]T\=]0d[7!DU>N7t@GFH\^!K**(!/h%"$[MDk W.h-h]k,fi?P9Z'aT;icPW1KFk,PU&1Zpq8D;i(&1[5[_@oRaUOT`\BA(s 9"`i@p(&[I`fpJtp-u/$[k"bn>LK,=%S]CrlW$A``\4CldKf]+?d^KnbN6]T>AJ?i Due40'-=Zrq@*hK/h?uUaS'[4Yb8uD/_K)``7"PAELZ,+j(K$;9=a1d5-9Psrr@os IO0DG;rIfEZsODW/4iFu[S7`uq3Lq3\[$IJ endstream endobj 51 0 obj <>stream 8;Z\t>7Q?0$q/eK#.pEF%9Hlb<\!Sr-S]@ndp^a`O8p`+laV3mnu_rY!J:asG1Q%: QV/+=o$,_o?Z%m((%B`fV$^p=\gSG0C1`O0,uZ>15N=b"Bj'PGC&NGt`U7LX_qDZg [5H$,/2'_uT3\kUVZc%Ud9&-``n:W_`S`I:GtD:2^=:/qbO2/g?W-I36b4)6,(lXa %84mfQmTjpb$D'fp:,Q!B8&Qe/_YH\Q_?F,;W#"[:A&O7 endstream endobj 63 0 obj <> endobj 64 0 obj <>stream HLTN0}W+5_P6Rn,M_eZiwsfN;ζ$'yekYҼO X̅>+ÍiAlMAd Wh-@5 3U a*/y}scdeg+dγ?Phyps,⚃ kx@\Ed_4\h\b3%`Lv Pߺn8}L\"X3JT S"϶=:jKeTcL$+BrA)f qaMS FX嬰DCgōAkڭ:6AcggB25!Q-nWKjN$shM 9e |^Mq)Fn -uHmb0>StX0kdG2}O CW|s jЕK :9_9!$:5.ᑌ2)U)q%Iztk^&Ǧ~*x1XSXiBiӸǘ/b>l 3H(U9LrC+8W+Ѯ7YAUp~_(gP &!T`># ^ۡyՃ2#xV$J\f"cmM~ھ%v=t#Kgݐvx7j` Q8V QQG endstream endobj 65 0 obj <>stream HdTn0 +rTԳDw 0lڃj3E*,YRM2'_ڭ=\~o:p1)]GQ+*b+Zr N&KQ2ֲі"[ܶ7!gIv}>l XZ#mx%Eو]f +Eͱ9?fX$ &ioڨ(+4ٙ'=J S`Bn(R= Չ-8Ks[2zq_ξCmDK?_nHĦ%iݝɖ'Ό'Trn\.R%Q,R7K4tȵ9ӘgbN\9G!Wxg}o&hmtW4="G۝($n}H\^Q % K.@/L(&QUa*~ N[Tš E V endstream endobj 90 0 obj <>stream ht+aǟav0hw.\Q[lkf\ Q.ӤRJNjkˏ(9"1Cy>=}{ !ߗt6FMsk94j՘no\赾p@K7^D 1X>stream hTPN0[p,R9}&gؖ{(l>fvgi?F(]D8 a/gF-ތږЏX\p[} 6N+&չosP8ڽ*fh}U8! 3! _#wqEx>ֱj#Ϙ5&:f, >rv&)edRKK\h5/;J^녝uiȏo} endstream endobj 66 0 obj <>stream HTAn0%E@/) oLJlɐzA]lIDrfv8`y0PdV6". qߊb>*jp6|\v2mMbYH˦OtU j꯸3E \tYfmwa1e}&u2G>N~~‚w2eS^$VoP!/ =EI:-Yw jB /Չ[au)ii:<'_~dC5,8˴L&-pQtsWijpdh, ,N{ 19J.K1d!ZŽzw2I"6h%a(%o^<9>6'tI*GKxǹk5g2S#6䐪DǬMKGW=[D'f>"ӭq D`-&kv\WeB%ԫ{Ax&4,9u%Q O<"_53z<~𿰩9OG\>'wΗ] v>stream HSMo0 W(gwPl+^k`vőTH=&OSw{Ulv>stream H|TMs W;1\;i;=U"! W.?+S޾Qa(qsCK "F,Fjɰ0j׊dʯN GN=JxIIgozt 63ۨ;lcڏSSBU$8ekb x9ײei( 2O7*?~bץߨ;4j2.ɬ#_źط'ȩSNIec TVrY6dkSv)(*x7^=Xl;לgLTpQe#ߒTP6e1*>6J"䁼6-E Fmrqh$I2#~bp:Ud·=lzX3T~(A8dp ;.IҳX:Wѽ>+fH)]]앜:s`'{J gaK&6I%q!Dby)lڒx1 kq(!OL`I]ұUp)FpZ:}9m9 DAF y:g>c endstream endobj 69 0 obj <>stream HlT=o0+wwM]uݮv?E7u%]|[3ͫٳ.4{n+lL&D9쏹_wvߨI%Tׯټ컳fI4)golks&f&`-uZ'7/*fF S[z]ձ3/EwTS] ?\E55>stream HTMs0+t(ABtMi6AƲI+c~}vQy;:l9i,k[e >stream HTN0E ک3fW@_j E.M&R.%;B sG=6xF1r]8]-7cς>/Ņ׍n릫 $P7ũZ].ukB$ )NEٽ#@-XFiyr,* z Fs$Q 1$̞SHuC>/\+f[lj׵cdA\5_z6ob xz]nӧ+^vk;T?~#[ g\Uc(yNF "&FڀU'׊[W(%H cLܾ(Jg* ? [3x endstream endobj 85 0 obj <>stream hdU TSW}b;F<&S ~D * XZM B'@jj[$Z6-R+֎ʨ tHk+bV?{sϚfZsg}S0JFP 6~ft UȾFg[,؆A '=x(=b%=@:Q 2C^YuT)"j2K |iANՖk i%)"+KZ!_Zj7欵KQKFfL3gmugɱ皥ɘ6j,46ДoIms?r`Ԙa 3“yZa%c=Ldf1\ГIdFp7X/ ^1#c/==5z՞zWRUصG2%Un-*fBSTTjWEǣǁk!n B8€P C{ClU͛U0c CC ;!VPwy@ rdYIz4jED sU9kQCTr1 gkﵩ:>j #s}pv${[ua)愀M_vG̃{v&=Nxw|6oʜF ƺs4$-\(B)_bky06ẹ8tA 2] > b)ָi 7wV]?lNHY\><` E'鼳Vt8lIꬽgvN]`I#N`!`ŀX" w8D]2.L Ņ8p;azAZ#L+^"D# xX: 6v.oh%2`2& _z'L8 "#D$HX?H&#Zpz31%9!,xEXcXq?ǁV 6_//M6lg!`!~u 7P(*G\-l)AoE+>,'}[Sr Akk RKgym|NAz=n3a:oX 䣞 ɸI6|+u"C8crFAQĞlJH'̉,EUG`  Ĉ5oZD0G2~Ҁ&*}ڻ5W2`4&<$b (slQx T@n>}Fֳ;V:/h>g2qAzi;Ӛm\C1yo]ېy&l}u*Ԓ}1#npyI`,/@;E~UGUSeZvg}؅ͅ%"> zy2? z|7 kmَ-;m*NG柍K]k<\]B]E ΃J>610(/}흚`7+xhF]sG5k! Dq~}8$Иb)K)D.W*"Cc^FDn Ge#a"!孚;13,#"(EPjʛ_I-J"VQV'~471Eu\@`sѺ6m;EP$Gw%gMI`/&FWmCZC|X)wt}jߡ.nx:zt{Bpv1џ;SDX_-~PW3R!koq?ru"^nRUeW?qe6m.-s~ B(4/[w? C߮>Znga, endstream endobj 86 0 obj <>stream htX TW Fc!T*+1*(*(* !5M74;4&K7* 5cIf'"Wɜ>O}}mi1nF3;B"EE (QU F2JLdYXYZխdžK>0ig޾;ߝ98G p.D9EEFGJ888;l3#9l OE"q!qX_0@(<:yoܨXwqBC|cCG˂n1zD-", X -*-[[6X޷m5jUe>j% l1҃l>bSZK{ޫ1z눖ȥ#KF}Nu6uc,8#刺ẕ㆏ >nIgӷlmm/OPa7.~ʾmlE$ѺaS0/ y/\ U}`x_'#,b=冲$ސ\3iS1ZUc್9=&cY-S,r7?nR2}Z"×∥ :sޣ]!%&`8p)٭jT079Ep^W g}cf[=sК\@<0o$'z|y˗/"O+J'!z S-y]C0Ǜg/޺;KºlEXKu.|k$6Tq+0_s0Нl$W% ŸL# M)ۡC)@V((N'e@3IX.ıotΌકĹG߱0~תqn%R𜾭Wvɬ:2.y\&I^(`>zNJƣvu ~1h2=}еk*yIa~om%6B.} KPz,25&<,99($ii1,hDJ]E݃ q޾}e#막L<G_58{ܛ]`m#l\E2W`0u}`?h45tg 뚬 пL^OU`bvΠH2ię,D=NBG u(gf_%{?ny^~c Kaؙҋȝk~yM9uɑ90τ)@ه;wt{`@,T撔r [!31h-Zsle1NΎ!JMo@Ԕt.Q+e?}UkנYᯢ+MI<:ww>~ڣTؒ'6߂ ӆofyiLFmt;ּ]7Ԑ#M%u|W@i#~q?:N[JW' hKх malre.Z$.IԤ9lUS?}`n"afOjag"cY`y1t}-($KZzH{ĒjX5$9zR&yUY̼ IN&t)ĉ'BP N,N!Z 9_!RNU"(}BC(~[^ެw-eUbRA$q$ `'kZ2x2*;T}*h+JoNh8_qE+^nXXLj"秛n0p.'*'~Xz\=*L*d ]xvs1wS&YW ^ =%: ZSCɓ|1RY Q8.ldb, \Χԧv"RmRG3!(RDQ5YQ:R0jc#L|b.YhoɠmqNr ~CwI j" 6 v\{"r ?Cb̐2ANuoRJ DKkt膎 nh'. Q8$jy?= D4e" 55OJy\{ 1:Jp:FT5$זw Тئ-@".=fZ֘!0mæh/߼aKPSq=*Iu1dQ;+t lu:kGcO?$lvK-`',d4N6٭Hmkӝhu&,JaO?\$y m(0lYFk[rq<9% \xM3uqx Nm0 AjGe,c?/]bjZnn2 >#|oCg{a lfrf.R2MDΟOilcvm[8 قAD i,ZN>baҭ/̕ӭ~6ߩ'eSMVMrlXA }Af ˚FXTJ2,㔹yb9u RKCS=–S5 d#!MtP-80P?WݸMfP_yXݩ:H}N3;BrZkdL f0ɨ~uej<:ng$!V0^،$Ug?#͌Ȕr8_|O(zRk*VJF5f/nwsN,"eNP˨ϕȶŇݧqaQ ;'Kކ͆r"ks2f "ܮpF @iӞъeEe ;;HKّc/d Է1֞F'?Q.)g£5U⎜2Q c΋ټbFl=OJJEI%22M%LS9vu<Ǩ2Ә;p5R%nvK&j6#Z;|ۿuыBm , ap%@,+X!܆~!TxpgE)? b@[:/bP7I_*ۧT&b'G` J Wpʌx60_\:J.S83RҥlOp:ZqK*jm0TsF#z?m ELc\;s˭d[}>)IXSH#V^!ְ=GiZ#}TTFTsA8[m}ys"oL8_m~; '0iWQ~ˤ_Lpa8YH<d=Ip :[y|^dZ_tq2H+wNXCx1/rpݳJ늤/(]9Gn{)w\IIdRS8=E| K.є|!Ck#U:KY^[X0׊$#Pzز|#0lNzs_u Vg 7R dS=f|+ [)FS6+š7HSVP9zO3^AtܔZI]~eڈ`EW~Im7~ٗI@ya/{&x=D:PBL^iCw4PFd 4:Bk8v570&Yֈ̴4E2#(\P9]))HIj41j[H3[Ez_1yG_o@FrZ`m$TsTqAm%'1RG S5zi=x 6&wgQF*FG/ԶԈc1 I6or}i}؝y,==)]-yg=楂>pkU {2h3e9_F^9c\z|[Z8@#ㄖuv 0p)_bh3$g:-\xȑ)DPVRkJ= koJ?xѣW~bwWTG0P۩OVч .4u` %z,tǞ1!a9]/)bqtBg>\;-|>n"w'KVDij_s4I2,yZ: FZ(Y}MoORHket!yڎꊃ;:=:$ $e~)wn[*-IDRfe$Wggp|>J01hWŅ1$L8%2 O_jʏ׾}q9ɻGkD`MvsPsq),mpE,.p">:>>>;QT\,#Ɯ>vK)!RaR+=lS1Γ1Jfgdr[>&S-6󩏞Hz+pGNN_~p NK1fkd}nM ry!3)pPeK}3ʭ6FtM־府ClᡚÃKz!!T*'I͎NcRGJ^ߞ/BWPʒn$桏^t2My]T(X.Ԑ^4 06貊آ,MU0Ҍpkڀ8èZ{#:*\)SN|J^W)rSPRMq7YWOT%CSCQR M[.c2Rң¬2S[&Seei,kg`CO.%2ݫȎ ; `N9(62/˓?b#FN( *syYH4 M#Z-|Lgzm\# <=un߮ԧ0XAmQ]sx%bHk{m\=|2źA΢ z!~׉ 6qx\(ݝd}"3 <)4'waFj>#IWԽq1 /ah.BA~V)kyzh.ނ$e38WQPAC+ endstream endobj 93 0 obj <>stream hlU{PSWA=Ե^7Xnmk(R@j"($$71B h*TvjYh_[u>:ߥ'37t霙=weDh!ɘu))kY ]tfqeS$>Yg=NdKJծtȼEʥqb{{|pV_@i y%M Rg2#Ufh 4z$@TiJ&7(W[YRܠ*.K 딹/(UR|Vը K~B&-iX@QXF<BD#F$#2[CNr%GedBVBӺj}dH9@^fR~.J@Zt:lq??r<%iS^:sg!~^AŐ'Ik4l=ۼHcfwn !&[+yPm/d ЎUA?a?)"-t-zJ]X#)?u1 6܂&!$q,x7Qcx8ڎ}ziu[@:J^6x{*F_*]m5hH H(E'kmNVCS)\p`^tx[&ՍR/Jj}Lj(馠MD:*sDG(թeP5_-B/ӡ~a` }Ň ԕZhU<5E+5ޏxZ|eT`x>xr/#p-̩8ZOUu%G7)>ȋ99XLPe02V`VQxGuutV@?A.Q̅Cg4mV/lN2b{BFXES x@7{T^ݳA+N!9!.ѽ|F_WTg,|פ96nǀ޵w5;x8l8&%Q, & :/C>&E{^g޼5*}o8!@VSxM 1VX "2?vOq6)W~:}IFoh^;@G41swQX\S4$sp =BےE>w r#^u@qRe|BɕbhMTM}RV6ZW.18V D>?7dvhtw@[r%zś_Kd|S0a3OZ0OI/bYfS`řx ¯$c|CTUk^Xr~ 4Tad`>O;aYj۝s0TBIyf,N7%>_x]Tӧ9| Tl}Eiv_9R~^3 qPuJ)9:iZ@w@̍V6LBX!+ox3`$ PIhdJZX-&s8_&V/\_FjV$GͺRO9/S i.* D?6OMWe UWj\plRc\ xOzkp|?<-cҲTb4pEk!5ժlbnO09ydw!XA47wWG`5?44z˟W |HʒD|hݓ⺩ZNVRx:MMZn(KsWz<6o` E\JH9%,lEZ|vHodMv#T2,_ZULh~ZSC! ^Y4?baţv[ψ 'N RD32ѠWKC/ 1PE6O2=֣. IdR.5<5V2* {]a3Gz^(ׇKOvԘwHC4N@%FgW݆7t-&PDQ-Rc۩"χws>5 sa9}B!w،sU@ Y[v3ng'0hZ\XMA9)ǮJb'< endstream endobj 72 0 obj <>stream AdobedC        s!1AQa"q2B#R3b$r%C4Scs5D'6Tdt& EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz?@7?1ӫiZyKtBHkV΅BS&],)1eRy/>[fk?XKBnb=랯-WOe3p,A 1+pu/rmS]6=BzK$4:TTmQ<<ůGykI}FK+{~SI*k´!_ ^d>M\хVr.גgh򄚟㤗WWRky$:r= i L\֑6ZoJ 2P+FŨhgXvׇIj)mX/ѻ:%vEe9R]pC^Z Z~f[~Ny?G$R8|P<9aw*K ?>,T/Y;?W=MoͶ0ǫc8g0'jzMR +Y.nd'o<1/MvVuY_G$a^`?9li86yYq[XbUYБ+Ok+GG?302\y槚o,OEi;[fVT ~T~^y3w~[`-$ylDDYT32toN0MQ:槚/8AE7Ek9CwmծNHfIхUAt#;Uuqe[[[*̱w@G'?=B%󞱦6y#ku+6~LK,UGW>\L9/385Jnn|2{}3ոӵi$Y+IHT~i`w&y;^Ӵ4Nm|q̶()( MT}Gŗ1kPM+5I+:K" sߜ~rK[ԌFzˇ?9[_MNKQ _"(ՠ@&q'풟]'G&vqsZڥ'#5.͹2?oqs8 {hkVcݠܒv<*#m[n?RV=r}gGaN v¬޺*dUdJZ1QOjΫiǩ=IjJQ 9:U;cVe3l~oj`u2=5źKΤZu9 򏕨+/4ƺyϘl'L9@DU=]yq]=բX{ax6.J 3w \ߑoˍZ[)[ڤH'N*Li79@YjZ?wK'44Z_ϩKoZ"R5K-7|*?%˿)-t(/Yij;|9r.?U\ԫ{k5fVj·O-BHm6u!ۅm_bп8u/:jZ5䷲E-qe 1_T5O;[ }f8-D{UfU<[s8[|jzdα8XksꚍۤBH YW<~h~`h\dӞ7KR5,Wo|w宯Wӯbѯo!eXY-tǏ5~eyuc pNQ*? UXSo?c})uVLbce<=1o|ukOklUH5%!vF{^bӼ3]6:"h& J"(j~hBy+-G\,zN2փ q?+~fWZf)R-BKT+N9GiLQ~2O̩4 WNk0z%:WzgPfmǕtf֬D-rQ4c*~XDy-i| {8 k+rqA)=0Nk'/uK&+˻[tKPO8LV#W~rykEJP^"̦`om&gT-yiC"}Hٷz+Z46 k6Zk6WB{`r;mJyK[_/k2Y36Lj-S^3UZח44P 7ŀT~힛_%U_3i+a 0tiƙeysNcEjTy/ ŧ\Ya2}]o>y2jn*x|<;䇕0u7SuL0 BOz`ͯ)eiv/e+MI&.(xg8$MާĶ`u+#Q"PaW_j'.t=Nw >9lxZ/WsFeB{)zƥ:E}"v5FxPKؼ;I#YN% * rH;7:2_Wִ82/ʶFଊRJ F܆{sFW??/M=n ZF4ёվ%#<=Gk<è^Z%iV[k#,@k=V󎖉?)> *[K%Pg2ېhniFdnRO/i+}`LRr;t=]&7W@'+VJE+?Sm4ԡYZӪTzs#%5?6wS0qiL/?g`d~xw?yğw^?? ̭[O-umHZR乒-3. -kđ_zGȞBѴ֭/-!DѠC Q?bW|$黪GZ$T}Mk_Zi>DUm+=V$AXkZ9jӥ+y;ϟgUE²ZvlޭdT<3/j7xdW6zGp^H%Ղ1;WD >3yմ嶷sIGqvXߕX7_5;dݭ"3v@T :4=ìk#9RBraO>arRd-ɼIwrePWdZ;{S_򯾺Y/×Zڹu-,`.ٰӤK8 '\my*1ǧKu91yjsdw AcI,:9}$E[920ZWi {7qY򶯫\yL5_njwΙ-KA]9-,݈@W QE:|ThZ& PM@1+yk_Ŝ-0T'~]GnVNᓾ9$^zU]?Wwn"7/峺o</>X5ӵ:MNFHRva68WTˋk.E3MrE&"Q=z{x/Fce7 pBR?rF<[~vyn$hSkV6rʴqq'?_0+-Y-5`G\u;BѵZZ[;}nWbELZ݇TsYz 6,5s13({̻/\??iom<u*ijyǻ|Dm:m?Y֯ΘlMހ뱯.xRKpKyZӼj3ZHaD$ ڤ ,ľn:G%]Izʹcq.R::<WӦ'AF{o=ז%VX;/rIY'fd;+̚䶠mMf[(~|NU0d6- wd>q2Ⴟ!|9y&_(^Y_t+am-zݤiN#36u k]J )絊icW.r |K4_UϘ=ksZ42Y +1_8Imkkk5Oui޴Wèvo}&X7-a;i9DBN] fi{Rk+a{i!xf$|(8[Ei8y3ʚ> +dpa.HXV_S|֖ޥ#y<)˗3ПOQq# ?K['kՃ9W+16A9 ~'> ~Ǐ9ozm^<|w QӿB~zX8q@i^y?ɾL{sC&޷_x h?Sq~Vo~8ɷ*5>t捧旑]z}94y[Xfd 4VTKơXzZX_]F QOvVV3Oռ!zaDe`{ [}NweD=ĂB7 *:a޵_5ֿߢm~Ԑs 9ijgs:_tKXci@iZ`/[?N~=_Wԋa ?ByJ^˸/=qHq5+ƕO?8*Lg2aЧʼnۺ&,`: >{QԼ-os*L1hxAİSlKA6&Ojf8K: wۦI5?&|jrLJmxr#3ϾOO.?5iY=P1ND,nT|(EpF#Pq41cݣEAi\k<7W@"7%ш5.(06o/,He])'q;02%%%_ߤzOU*'c/Wz¼^r!̟ŏ(WNԱ[ޖe6ikjj9;ORkk11V}/QԬ =o$VB*O4e+yW 5*8ƽE!l,)4]RyjU X0s1B?%"?voTL\4h^hu ^i7" vVٔ?=Wy'ͫ-jڼsJX2EGjo+b=ðkqR{b(+Jjsַ6֏ēC#PyK <[mp~;3y_qEϗ;kkyG* I G?Ծpd#o"?#%Mnu w(V({Ǧu˯ OMpmHuVg%RV2N@aa3yGD^!I5SC#bE姛DIX],xE A e½rC:SMBUֆ(=>?KWn<_?X޿y\iM axg")4j"0ꬬx_ǟ[m|..fa0E[;UUOar'ߗ~kl<.= =y Y ALWc%#<)&P~p:+#5Z"-Pz|;,~R6o,jzr]0rKU=5/QfY%^|g2 ̿9baMie Y{o>B^_2QMhVRYO\~|:[VY~ ͽIh@AZlr/%k[ӤE[.b&xoPO^{UDڥ_qʬS8OWayl=VMJz5Ρ1?~R/,ma/-oop9PvJ:0Ry3~Yי,fKBHaPghq^, yCΟv־]:IqL`-6l&G>XI [F|!~_OSN|cUϬb2A8s??'Eǜ&q5mk?<4;7Dl#_Lu;~`Gq=6R@o1rOo[i֢PfE-iZѧΩ$,+D!qg}L~J~Y~cyɼq~tki-#Jk IJ瞉}ϒ?0,N.q,mxXPao>-nȶi ȯa$.rNOmYJד%)笿3'm[YO3LmmQC"iW+\sܟ?qŧ&dҗ!*ȴU끡ԤC4_a7 >)Z5i\?302\xo8?3y\Am^Ks Rdjc"#qΞ]󞉮Zl]sE͒^QRs?[`I6?K&Fy"򵆠<2LtB+J olvw7/Mmw^3fi[`?áe县{qn}[RMY5?,(MMoeE:$X-5j%*W\psyvȐ~_uŦAku("(ާaQQ緕WRke!h˖n\zgn&Fo=[%2;L%l{SƇo骶Ϧ0'sOIz3s6y^&-TxgW⿞|76Z퍺jqz ZPI_xqP͚-/4/ꗶq=ɒhlϯ$huBwO(fjWZNIRUq8WL5SX=q+?W#Id༫ZW>xy:K/nƥϭ,]z~uΟNM9a-doXo>=Z~d~ӿQu7Gyg0?V`~#ҾS"п#=~~Rroo o[z_rۏ<boi^HPX4|×#igEc$: tO`1sXܽNHA4o&[B^.R*{PSCe~/C|~*LzAzs~Jߦ#\}H&zޚ4t~#z|&G_Xb_\HAcXoW/zaW5վGt/m>sdEfd+q<喞Sa&] 'Nh#Rɟ$Mh~^99 \ 59p6.?@O7<<$1G×^3-M~GKozgk:P=KJz}.=_Ss endstream endobj 94 0 obj <>stream hތR}LSW}}ES^NF|Xf4 D+vsVI(k 2 ZG`!b4nNqdӨ5j?6sΉlr;>_˹97{~h̴.Y=+Y1yZЈ?~I'bO"Rt'i׽/fJde6ƿ|sI>'eyrJRjIlOZ򹼕$UR'9$t:%[]]sȣ)5Sr9<^M*NvbCQ(HQfZHQVESKjwT:N+i?F)R(.+*G',ŋdAܩj-9ځA+T@:LGУc?!rL4#[.#A@ȹ}hUׯjz['Ζ# o]=(/L;PZTkYvCҝ+w\7,6շaX׹;'n*mW`՛B]ѰJSîYumͶwC"A0qbëRp p0*<1 h2[}0Iۖd1<E\MjPgP%IB=jVjDMrgÎZ<M)8c0#7pE μ8N] zwDkGHԖ> 1)0Mebc[ɷ#7[-Ա璘h pr+Vy/t8hZe@x+Pu~S>-ܹ5Ȇ|@`J[Z8Yq}zZWzA_Ch<8A|)|0̓ |a}Sz4PC촂hfwC6QoR@w狫DŽ`,&yI)+ endstream endobj 95 0 obj <>stream hTU Pa_#A0=i\ ȘdD* نDDep"0wEĄhĨ;X_usߕQ J& ^ƈLcB-{y &qSNLVWb,Լxfu64YG?&$=`ĕ 4Q9sMy&}1}Flf(Bd,0%,bcab&@l=MMLVNnaIQ{4YoA +=Ko2L(P)ʁT5چGQdS:JSo*NN%(JCQT1UG]yޗ=񶉴)9n󛜖W7/ɟ)t5NJW6}Pd:YC.gtB&\a]ka#4*-1Pu%+VԿg7w~A"6``IbbxKCgώ9c8ߧtxS15Ct9K!RRpᕀ8v&E2$l#R(aȞ#`48wrf,T.ŢnY_\o\pR2 D ^؆ƚ2󏉟o|Sg%l?w47mB-s18[#'=OG3,!>eT" 7+#{}v{x9E7?T8{Kfx&,*.b7$Tڿ|!Z|m>܍q ({{w%@;h30ux*Tdc_f{G/f/NNR +َ+_!Vv7.Lj#G52 B_G#/P wix*N& A1x1U4mn4 =,0p%xVV}jW94z`>q0,v`Rep8s. | / iveW a120 x [=Z ѴJ%4NLSOa??_\W~kiP$\d>*Zŕmj,jt#뛌6ŋsPDxaMW a2LJF`a lı>(x-sK} ML\|2At"0;3oΣݨ݋]w7_W*&1`nvpKcuSN^$ R_[ b _7[--O?&U [9PF0W\{| wYxiT,|Z4"kʸÜLu?8юQ <ΝL؉%K?LtVbpÕkb~Uc;v 6:9ouǭM;A^fV]CL̶7}vyS2JqJla&x$OCbϠ^vhY18bh F髍9H&Ѡwk tڕ@e//M J֯+ Л![!NX:G>' endstream endobj 96 0 obj <>stream h5QT% jҴiqikU\"K.PJk4FtGsorϽ|q^Y3ҭT[٬̸7?]eh7->'2Xl4ǂ91 c1XKc,cٌMgʱb1Y`oCř$n%u3>}{d7U %g6raqźuե5HNS8-bK(?4?D{*;:)5l<2OYN SbL<&nAk2gq/!|pa;ZOO)Y. ]s@\="'+`IXtb0Z4, QtM]l|T8(TLQ6bUZlR8ӧȓK˗@YF]a=D#Еykk]vG8ֶ8 2M&PW 0Y z$:Zpy '3y) ;} ؀g|@ lgT/,Q z7g9yHzq{̽2^gz~ZSRWzjG/jjgyQ=Jp@¼+ʥ0s-ć s R %O i%GM#SDu_ǴVjT9C XsBv@F^MS V(,B]䉩ky|PU-2STR/gN(q/ %5Om֐bIsJ6F%w/b{hkHx%#g m=^j%FVN1R~+Ja#꥽((Ԩ?V\u\4L%t^e`[ СdC<&&c4MDB9`Ґodr/0zևļ>0=N1z"6$J5=R1`Dbgnj<JEIou 0Ed endstream endobj 97 0 obj <>stream hdT{PSWr]wW˽ި֊(VSD!&#H@P*mA;cg]^ܙ{}g>烰Xpp~L!n%54]a26(ZPuҳC$RohocpЖw5x*Sļ,NvgR#ԉSx|w`A; ֊5N O y:0Ujyc(YR[ # ʌ\Ć5t<לf5 4 M^ ^@gG5Kvpw#hu_KYa tc#*[:WlǑs`3W=/3J6?$zgC?lEgM=rn&`>&Ө$Tiu]A->Ȥ\& ኴ5}>lr%Y9xռ{"3*j.>ESUmEBNhLq` _t,=H:t.8eɣ%.kj=i4 $\C:Lx%KEDe Uκ+`[u|UR0@un,j(11p- I/N\ .2'nm&ʱ 干kzI2RF"Ǐ?itV4P@>-ad~ýp1J/;p58:HJ=K .EWW.&3(iZV"+ov2حNm;ٯ7\= `\f" ~Bp&1mk`=O? C.|]}mDG[ew J_]rrSYHB,.,#$RnDSǚEj\vA@.*7`v Zl*8 F^Dwگ LDIf,gK%\ ' S"{䵉;HmK0( vt.-hGkB4FP9O6oZWll(=OmKtfVM? ~삉>&6v"_aFf.ؿN endstream endobj 98 0 obj <>stream hdkL[eaĨp^XmV qrZB!lBiilR{Aa  b41[4cёޚχs=pޗn(tYz1fyc'e'6;<ƢpwXo0\mIOWizDӘLeN#=o*#NaL)\V`N`TWY01^o4X&3QիS<ÅS9ϱBb dXX)Vbh0j(uϻm)#~]!Ssӓs3gʷkkhx3Z9ņ+ao:쩫hxpO68ђ(᡹/1~9V:TS{@#eB/G`v+ 5}X+@PbS_l+ RN)]r܈s iRJ'V:[ʩ[8޴eݤD3& )>8B=Dn0¿\,qt}UuB pSDB/WXpzJOƠɶEa_+7ݴt*$ +x{1~TN,ɴy&.P d26^XK!h&!"vyC8wEC9s0ʓгH2|dupkARwђl~j|='P ﺅb묤,4Y5Gt n[$|جjRz%9JTJP[v [Z~bw~^ҟr@&51Zy7{Ed1fKC* 0qԨp>dvip_ )Q*s D&x:]gy01XR qL6Mq@>Jvo[{A[]Fwq[0ƛ$|!'k<:]jӪŽMԷ.„y!ٞ N{ endstream endobj 99 0 obj <> endobj 8 0 obj <>stream xZks۶+Νg:$q?j9[?l)gBHʲIH!]`J(`b^1g~"`H/R2_2)=>>Le2NX`QѨ"d*F5G 0 |%_ȘJx1~1}cJ DH CcVBLB_(C4,Y䡤Gh C$$Xa8fq($Y"O tfIEĂ% D.X};,/[O%7g9酪6TgoNtwgh<dzY6vP]t׳<;Ǣ;a34?YN/Nt^k~r1F8^̇s~3~s)nQ_|oƃ{Ixaw֏:/iVM'UQ}=ƒy3?~!u,9jz4N-FF@#ِFɄwogP}>C>K1󔏸|sWc>S~+醴&g ?!"?hy^Pj9|Izab@ya:|aq1?t72 iدR#qt2̮' [.SkyAgX^vjMa}A8Wf/%󭛐IUK2 4.ռTJX}]>~Ʈm_}pir @g(?@^ۭF^C}0 ^y^4Nr,jah%Ͱb@@U:H!>J)Q~G﹋h\a+e읭bl*c ;yscԊmҳzgo0cb q2UQ  pEF}F\9J6@k jGrW$|HdxߴSk=ێ]uΡVi Qin{ W4)7[ b.9-PwN/GDv{xEn x;:1Eq縷#ʒ̀Uoůu"cybhsЎ-,,SˈUORb>%ٟrȍ`ms18S3gPѩNtӠ(??xE؂<#%PCEk`[_;jT,bzmkRc?êϡOMe G~/]xOOVћTprbjOb>׃a6bⱳ@v7-vArKkn^Q)&GY1J.+@ &Խ鬳OM/b^]M,/Lkmp2).4-gpVlݸ`)C`xUkkۭrm籭R"2+ܖ0rvnfF+.ꆩYg Kj˕VWQnmU dKՎ+ rM]w_"͑"5>j$#~u\wdw?>C]~G,t!-`Jh1O-Q|;!OgUwN{; VQ`tH& hnK?dz|0_;`eOHBBg{zŞ,flf7 9\/:7SyDqotl.)Gםh}*rN9htt6?@ϿlBů&Ou|IԬokj3N@̓['[ti>-*' p.'o^JW48`PI>ر?$B-!1a荾oi4m"TFH_~U?D6j8Qz} ^hsv#e4'qe:)ۚIGmqbay@x=%&l9ڻĶv. endstream endobj 100 0 obj <<283afe4e92f2854247a763522bfecce6>]/Root 63 0 R/Length 316/Size 101>>stream x5н/CasmgTJ^"A"Ab1YEb1w`14"H*ְ]}/'=y^WWE, %0 >a}1 )zF`rќ̰I2V)E--U /-{iNQ\4rw<5n endstream endobj startxref 117694 %%EOF